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Abstract 
Mushroom sclerotium is rich in polysaccharides and the polysaccharides 
isolated from the sclerotium of a novel mushroom sclerotium Polyporus rhinocerus 
(PR) have shown potent in vitro and in vivo antitumor and immunomodulatory 
activities. In this study, two sclerotial polysaccharides isolated from PR: a hot 
water-soluble heterglycan-protein complex (PRW) and a micronized 
sonication-assisted cold alkali-soluble pure p-glucan (mPRSon) were studied for 
their immunomodulatory effects on two antigen-presenting cells (APCs): human 
monocytic THP-1 cells by in vitro study and murine bone marrow-derived dendritic 
cells (BMDCs) by en vivo study. 
In vitro immunomodulatory study showed that PRW had significant inhibitory 
effects (p<0.05) while mPRSon had significant proliferative effects Q)<0.05) on 
THP-1. At 400 ^ig/mL, PRW stimulated observable morphological changes in 
THP-1, while mPRSon had no effect on cell morphology. THP-1 treated with PRW 
at 100 and 400 |ag/mL showed phenotypic maturation by increasing the expression of 
surface maturation markers including CD14 and CDllb, as well as MHC class II 
molecule HLA-DR which provided a linkage between the innate and adaptive 
immunity by presenting antigen to CD4+ T cells; significantly up-regulated 
phagocytic activity ofTHP-1 by increasing the uptake ofFITC-labeled dextran. 
THP-1 treated with mPRSon at 100 and 400 ^ig/mL had significant increase in nitrite 
production determined by Griess Reagent System. By human cytokine array, 
THP-1 treated with both mPRSon and PRW at 400 p,g/mL were activated to release 
cytokines that recruited and activated neutrophils and monocytes. Stimulation of the 
release of cytokines that activated NK cells, T and B lymphocytes could only be 
found in PRW-treated THP-1 cells. “ The sub-Gl phase ofcell cycle in THP-1 
treated with PRW at 400 ^ig/mL was significantly up-regulated, indicating the onset 
of apoptosis. 
ii 
All Qx vivo immunomodulatory studies using immature BMDCs were conducted 
at a concentration of 400 p-g/mL. Treatment of PRW induced cell differentiation to 
maturity to a larger extent than mPRSon by stronger inhibition of cell growth and 
morphological changes including cell enlargement with veils and dendrites and 
adhesion onto cell culture plates. Moreover, immature BMDCs treated with PRW 
showed phenotypic maturation by a significant increase in up-regulation of 
co-stimulating molecules including CD40, CD 80，and CD86, while those treated 
with mPRSon had a significant increase in the expression of CD86 only. Immature 
BMDCs treated with both PRW and mPRSon had a significant down-regulation of 
their endocytic capability as shown by a decrease in the uptake of FITC-DX. 
Immature BMDCs treated with PRW and mPRSon became functionally mature 
stimulated by secreting a wide range of cytokines that recruit and activate different 
types of immature immune cells as well as those that promote the polarization o f T 
cells. PRW-treated immature BMDCs were differentiated into immunostimulatory 
DCs (TipDCs) instead of the classical mature DCs as demonstrated by an increase in 
nitrite production and a decrease in the expression of surface marker CDllc . 
Binding of surface receptor monoclonal antibodies (mAbs) on the two APCs 
pretreated with PRW and mPRSon was investigated by flow cytometric analysis. 
THP-1 cells and immature BMDCs pretreated with mPRSon blocked the binding of 
dectin-1 mAb, implying that mPRSon activated immune responses through the 
binding of dectin-1 receptor. Pretreatment of PRW with THP-1 and BMDCs 
resulted in the blocking of the binding of CR3 mAb and dectin-l/TLR2 mAbs, 
respectively, suggesting that PRW could be recognized by multiple receptors in 
different immune cells. Production of reactive oxygen species (ROS) in THP-1 was 
significantly inhibited, which might be mediated by the binding of CR3 receptor by 
PRW. 
iii 
This study aims to investigate in the immunomodulatory effects of PR 
polysaccharides onAPCs as well as the mechanisms ofhow the PR polysaccharides 
act on via P-glucan receptors to exert such immunomodulatory effects. It 
accomplished the purpose that provided a deeper understanding of the 
immunomodulatory effects of the sclerotial PR polysaccharides on APCs, and also 











0.05)，而mPRSon則有顯著剌激THP-1生長的作用（p< 0.05) ° 在400 ^ig/mL 
的濃度，PRW刺激THP-1有可測見的細胞形態改變，而mPRSon則沒有細胞 






細胞因子譜組列陣測試中，100和400 ^g/mL mPRSon和PRW所激活的THP-1 
細胞釋放能激活嗜中性和單核細胞的細胞因子。釋放能激活自然殺傷細胞、T 


















的BMDCs上阻攔了 dectin-l mAb的結合，暗示mPRSon通過與dectin-1受體的 
結合而激活免疫反應�PRW的預先處理在THP-1和BMDCs，分別導致阻攔 
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Chapter 1 Introduction 
1.1 Antigen presenting cells (APC) in Immune systems 
The immune system in both mice and humans is divided into two parts: innate 
immunity and adaptive immunity (Figure 1.1). Innate immunity is non-specific and 
immediate host defense against infection and involves physical, chemical, and 
cellular barriers, endocytic and phagocytic and inflammatory mechanisms, while 
adaptive immunity shows highly specific to antigens and triggers memory response 
after the first exposure of the same antigen invaded. However, these two systems 
do not work individually. In fact, they act closely together to fight against diseases 
by identifying and killing pathogens and tumor cells. Antigen-presenting cells 
(APCs), including dendritic cells (DCs), macrophages, and B cells, form such a 
bridge between innate immunity and adaptive immunity (Kindt et al., 2007). This 
project will focus on DCs and macrophages. 
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Figure 1.1: Immunity and antigen presenting cells 
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1.1.1 Dendritic cells 
1.1.1.1 Differentiation of dendritic cells in mice 
The development and origin ofDCs are controversial. In general, different 
subtypes of DCs are generated from hematopoietic stem cells (HSCs) in mice bone 
marrow (BM) via myeloid committed precursor (MP), and lymphoid committed 
precursor (LP) (Geissmann et al., 2008; Geissmann et al., 2010; Kindt et al., 2007). 
MPs differentiate to myeloid monocyte, macrophage, and DC precursors (MDPs) 
which then give rise to Ly-6C+ and Ly-6C" monocytes, macrophages, and common 
DC precursors (CDPs) (Geissmann et al., 2008; Geissmann et al., 2010; Kindt et al., 
2007). CDPs differentiate into pre-classical DCs (pre-cDCs) and plasmacytoid DCs 
(PDCs). Pre-cDCs leave the bone marrow, and circulate in blood (Geissmann et al., 
2008; Geissmann et aL, 2010). They can then develop to CD8a+ CD4' or CD8a' 
CD4+ classical DCs (also called conventional DCs) in lymphoid tissues, or double 
negative classical DCs under inflammatory conditions in vitro (Geissmann et al., 
2008; Geissmann et al., 2010). CD8a+ CD4" classical DCs do not express CD1 lb, 
while both of CD8a" CD4+ classical DCs and double negative classical DCs express 
CDl lb on their surface (Geissmann et aL, 2008; Geissmann et al., 2010). 
Pre-cDCs can also develop to CD103+ lamina propria DCs (lpDCs) in non-lymphoid 
tissues (Geissmann et al., 2008; Geissmann et al., 2010. PDCs can also be directly 
differentiated from LPs (Geissmann et al., 2008; Geissmann et al., 2010). 
In steady state, Ly-6C+ monocytes can give rise to CX3CRl+ lpDCs in 
non-lymphoid tissues (Geissmann et al, 2008; Geissmann et al., 2010). In 
inflamed tissues, Ly-6C+ monocytes differentiate to mature monocyte-derived DCs 
(mo-DCs) which may produce inducible nitric oxygen, and thus are called 
- - 2 -
immunostimulatory DCs (TipDCs) (Geissmann et al., 2008; Geissmarm et al., 2010). 
But Ly-6C+ monocytes can also differentiate to immunosuppressive myeloid-derived 
suppressor cells (MDSCs) (Geissmann et al, 2008; Geissmann et al., 2010). Under 
inflammatory conditions, HSCs may by-pass the steps of precursors, and leave the 
BM, then directly give rise to myeloid DCs (Geissmann et al., 2008; Geissmann et 
al., 2010). Ly-6C+ monocytes are believed to contribute to Langerhans cells (LCs) 
which stay in epidermal layers of skin and can renew independently from the bone 
marrow (Geissmann et al., 2010). 
1.1.1.2 Maturation of dendritic cells 
As mentioned above, mice myeloid DCs can be generated from mouse BM. 
Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts as a growth 
factor to stimulate the development of CDPs into immature myeloid DCs, and 
interleukin-4 (IL-4) as a support factor to enhance the production of interleukin-12 
(IL-12) induced by maturation factors such as lipopolysaccharides (LPS) or high 
levels of tumor necrosis factor-alpha (TNF-a) (Geissmann et al, 2008; Geissmann et 
al, 2010; Menges et al., 2005) 
DCs link immune immunity with adaptive immunity (Figure 1.2). 
Dendritic-cell polarization is influenced by the type of microorganism that is 
recognized and the site of activation (Kapsenberg 2003). Upon a stimulus, 
immature DCs recognize and internalize DC-polarizing factors, type 1, or type 2, or 
regulatory-type pathogen-associated molecular patterns (PAMPs) using particular 
pattern-recognition receptors (PRRs), or tissue factors, such as chemokines, 
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interleukins, interferons, transforming-growth factor, etc. They might further 
develop into mature DCs. In terms of phenotypes and functions, CDPs, immature 
classical DCs, and mature classical DCs express differently. CDPs are unable to 
perform endocytosis, but they do not express major histocompatibility (MHC) class 
II molecules, co-stimulatory molecules CD40 / CD80 / CD86, and DC maker CDllc, 
and suspension in the medium with a round shape. Immature classical DCs express 
low levels of MHC class II molecules and co-stimulatory molecules, intermediate 
level ofCDllc，exhibit a high endocytic property, suspension in the medium with 
little and short extensions, and may release some cytokines. However, mature DCs 
appears like the dendrites of nerve cells with long membranous extensions, express 
high levels of MHC class II molecules and co-stimulatory molecules, release a range 
ofcytokines to further activate other immune cells, but they do not have endocytic 
capacity. Mature classical DCs express high level of CD 11 c, while mature TipDCs 
express intermediate level of CDl lc together with nitric oxide production 
(Geissmann et al, 2008; Geissmann et al., 2010; Menges et aL, 2005). 
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Figure 1.2 : Polarization of dendritic cells and linking of the innate and adaptive 
immunity (Kapsenberg 2003) 
^^1 ^  k IL-12family 
* ^ ^ l ^ 
-.¾ ^^^^r"t^ 
i^hJ-Q-. 
g r _ 1¾ ^~~^ 
Figure 1.3 : Three dendritic cell-derived signals in T-cell stimulation and T helper 1 (THl)/TH2-cell polarization. (Kapsenberg 2003) 
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1.1.1.3 Stimulation and polarization o fT cells stimulated by dendritic cells 
Type 1, or type 2 or regulatory-type PAMPs or tissue factors selectively activate 
and polarize immature DCs to become mature effector DCs or regulatory immature 
DCs which generate three signals to stimulate and polarize naiVe T cells (Figure 1.3) 
(Kapsenberg 2003). 
Signal 1 is the antigen-specific signal that is mediated through T-cell receptor 
(TCR) triggering by MHC class II-associated peptides processed from pathogens 
after internalization (Kapsenberg 2003). Signal 2 is the co-stimulatory signal. It is 
mainly mediated by triggering o f T cell CD28 by costimulatory molecules CD80 and 
CD86 after ligation of pattern-recognition receptors (Kapsenberg 2003; Naik 2008) 
Signal 3 is the T cells polarizing factors produced by immature DCs and mature DCs. 
Different types o f T cell polarizing factor stimulate and direct naive CD3+ T cells 
into different types o f T cells, such as immunogenic T cells or regulatory 
immunotolerant T cells. This polarizing signal is mediated by a range of soluble or 
membrane-bound type 1，type 2, or regulatory T Helper cell polarizing factors. For 
example, interleukin-12 (IL-12) family and CC-chemokine ligand 2 (CCL2) will 
promote the development o f T Helper 1 and T Helper 2 responses, respectively. 
The nature of signal 3 depends on the activation ofPRRs by PAMPs or tissue factors. 
These three signals normally occur in the case of mature DCs, while one or two of 
them, such as co-stimulatory molecules, might be absent in the case ofregulatory 
immature DCs. And the optimal expression of the profile of T-cell-polarizing 
factors often requires feedback stimulation by T cell CD40 ligand (CD40L) 
expressed by T cells after activation by signals 1 and 2 (Geissmann et al., 2008; 
Geissmann et al.，2010; Kapsenberg, 2003; Menges et al, 2005; Naik, 2008). 
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1.1.2 Monocyte and macrophage 
1.1.2.1 Differentiation of monocyte and macrophage in humans 
Mononuclear phagocytic system consists of monocytes in blood and 
macrophages in tissues (Figure 1.4). In humans, hematopoietic stem cells (HSC) in 
bone marrow develop into common myeloid progenitors (CMP), which further 
differentiate into promonocytes (pro-Mo), which leave the bone marrow and enter 
the blood, where pro-Mo further enlarge and differentiate into mature monocytes 
(Geissmann et al., 2008). Most of them migrate into tissues and differentiate into 
specific fixed tissue macrophages, such as alveolar macrophages in the lung, and 
Kupffer cells, or free resting macrophages traveling throughout tissues. However, 
others remain motile in the blood. In the steady state, bone marrow is a reserve for 
monocytes and low levels of free monocytes circulate in the blood. Upon infection 
or inflammation, much more monocytes are released from the bone marrow to enter 
the blood. They migrate into lymphoid organs or inflamed tissues or tumor cells, 
and activated by phagocytosis and recognition ofPAMPs with PRRs, or cytokines 
secreted by T Helper ( ¾ ) cells, to differentiate into activated macrophages or 
monocyte-derived DCs (Mo-DCs), in the course of an immune response (Kindt et al., 
2007; Naik 2008). 
There are two subtypes of monocytes grouped on the basis ofthe expression of 
CD14 and CD16, i.e. CD14+ CD16" and CD14+' — CD16+. Both ofthem express 
CD115, CD1 lb, but contrary to mouse monocytes, they also express MHC class II, 
and CDl lc (Geissmann et aL, 2008). Human CD14+ CD16"classical monocytes, 
which have a larger size, have the expression of monocyte chemotactic protein-1 
receptor 2 (CCR2) and L-selectin (CD62L), but low expression ofChemokine 
- -7-
(C-X3-C motif) receptor 1 (CX3CRl). However, human CD14+z _ CD16+ classical 
monocytes which have a smaller size, lack the surface expression of CCR2 and 
CD62L, but have high expression of CX3CRl and lymphocyte adhesion molecule 
(LFA-1; CD1 la/CD18) (Geissmann et al, 2008). Increased expressions ofCD14, 
CD16, CD1 lb, CD68, and MHC class II could be regarded as differentiation markers 
of monocytes to macrophage (Ding et al., 2007; Hsu et al., 2009). 
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Figure 1.4 : Typical morphology of (a) a monocyte and (b) a macrophage (adapted 
from Kindt et al, 2007). 
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1.1.2.2 Changes involved in differentiation of monocytes into macrophages 
Monocytes are much smaller in size than macrophages, and nearly without 
pseudopodia. They remain floating in blood or lymph. When monocytes differentiate 
into macrophages, they enlarges five- to ten- fold in shape, and increase their 
intracellular organelles, especially lysosomes, in both number and complexity 
(Figure 1.4). They also enhance the ability of adherence, increase the ability of 
phagocytosis, produce higher levels ofhydrolytic enzymes in lysosomes, and start to 
release a range of soluble factors to ingest and eliminate pathogens (Figure 1.5). 
Macrophages can be further stimulated to become activated macrophages (Kindt et 
al, 2007). 
()Bactcrium bccomcs J j ^ ^ 
attached to membiane _______- '^ \ w J \ 
evaginations called I j ^ ^ 
' ~ ^ ^ i M ^ 
V Bactcrium is ingested. L c ? ^ V p ^ ^ 
formingphagosomc ^ " ^ ^ Q 1 ^ ) 1 1 !T 
( ^ = ^ 3 t ^ % 
丫 二 ： 一 “ ^ © 1 ¾ • 
0 j > < w k 
1 Lysosomal enzymes ^^"^'^^^ ^ ^ ^ ^ V - ^ ^ \ 
digest captured material 3 t ^ ^ : ] W^ 
® 1^-^^ 
Digestion products are ^ ^ ^ • •• ^^^C^ 
released from ccU • •• • 1 
. I I I • • 
Figure 1.5 : Phagocytosis and breakdown of a bacterium by a macrophage (adapted 
from Kindt et aL, 2007) 
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Compared with resting macrophages, activated macrophages demonstrate 
greater phagocytic capacity, increased release of cytokines such as proinflammatory 
tumor necrosis factor alpha (TNF-a), or regulatory interleukin-10 (IL-10) to affect 
other leukocytes as well as monocytes and macrophages themselves. They are also 
more effective to kill ingested pathogens by secretion of reactive oxygen species 
(ROS), and reactive nitrogen species (RNS) (Figure 1.6). The production of ROS 
by macrophages is triggered by phagocytosis which stimulate Nicotinamide adenine 
dinucleotide phosphate (NADPH) phagosome oxidase Q3h0x) enzyme complex to 
produce a mix ofROS including superoxide anion ( • O2— )，hydrogen peroxide 
(H2O2), an hypochlorous acid ( H0C1). Phagocytosed microbes are ingested and 
internalized in phagosomes, in which ROS are used to digest ingested pathogens. 
The oxygen comsumed and uptake by macrophages increases several fold to support 
ROS production, therefore the production process ofROS by NADPH phox enzyme 
complex is known as respiratory burst (Fang, 2004; Kindt et al., 2007). 
Furthermore, the RNS is generated by higher levels of inducible nitric oxide 
synthetase (iNOS )，an enzyme that oxides L-arginine to generate L-citrulline and 
nitric oxide ¢40 ) : 
L-arginine + 02 + NADPH • NO + L-citrulline + NADP 
iNOS 
Nitric oxide can interact with superoxide to generate peroxynitrite ( ONOO— ), a 
more potent antimicrobial substance (Fang, 2004; Kindt et al., 2007). 
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Figure 1.6 : Generation of reactive oxygen speices and reactive nitrogen species 
(adapted from Kindt et al, 2007) 
Moreover, their expression of MHC class II molecule is increased, which enable 
activated macrophages to present antigens and activate T cells (Figure 1.7). After 
phagocytosis and processing of exogenous antigen by macrophages, some digested 
products may interact with MHC class II molecules, moving to the cell surface where 
they are presented to T Helper cells (Kindt et al，2007). This is important to 
collaboration between the innate and adaptive immune systems. They can secrete a 
range of cytotoxic proteins, which are not secreted by resting one, helping them to 
eliminate a variety of targets, including infected cells, intracellular bacteria, and 
tumor cells (Kindt et al, 2007). 
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Figure 1.7 : The process of antigen presentation by a macrophage (adapted from 
Kindt et al., 2007) 
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1.2 Isolation, structure and activity of mushroom polysaccharides 
1.2.1 Sources of mushroom polysaccharides 
Mushrooms with distinctive fruit bodies are classified as macro-fungi in the 
phyla Basidiomycota and Ascomycota under Fungi Kingdom (Moradali et aI., 2007). 
Many mushrooms, such as lingzhi and shiitake, have been extensively consumed for 
hundreds of years. Some of them are not only edible, but also are reported to be 
medicinal. Mushroom polysaccharides exert antitumor effect not only by direct 
inhibition of tumors and prevention of oncogenesis, but also by modulation of the 
immunity of the host. They are mainly extracted from mushrooms fruiting bodies, 
mycelium, sclerotium, spores and culture broth (Herre, Gordon and Brown 2004; Lai 
2008; Lai, 2005). Mushroom polysaccharides are the structural component of 
fungal cell wall (Figure 1.8). There are two major types of mushroom 
polysaccharides: rigid fibrillar of chitin / cellulose, and matrix-like ~-glucan, 
a-glucan and glycoproteins (Zhang et al. , 2007; Zjawiony, 2004). 
Fibrillar layer 
Mannqprotein (400k) 
.. Olucan (50-60%) 
Glue Chit in (1-9%) 
. Pfasma memb 
Figure 1.8 : The structure of fungal cell walls (adapted from Bartnicki-Garcia, 1968) 
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1.2.2 Extraction methods 
The use of extraction method is to break the outer layer and the inner layer of 
the fimgal cell wall, and isolate the high molecular weight substance. The 
extraction methods can be varied from mild to strong conditions, and chemical 
methods and physical methods, depending on the structure and solubility of 
polysaccharides (Zhang et al., 2007). Therefore, mushroom polysaccharides with 
different structural characteristics can be obtained by different extraction protocols. 
There are two different extraction protocols which differ in pH and 
tempertures — hot-water extraction, and cold-alkali-sonication extraction, commonly 
used in our laboratory (Gao, 2010; Lai, 2005; Lai, 2008). Hot-water extraction 
yields water-soluble polysaccharides, while alkali extraction yields water-insoluble 
ones (Zhang et al., 2007). Sonication is a physical method make use of ultrasound 
energy generated by an ultrasonic probe to disrupt fungal cell wall polysaccharides, 
so as to increase the yield of mushroom polysaccharides (Lai, 2008). Before 
extraction, micronisation techniques such as ball milling andjet milling are used to 
minimize the size of mushroom, so as to increase the yield of extraction (Chau et al., 
2007). After extraction, the isolated polysaccharides are further purified by using 
dialysis against ultra-pure water to eliminate low molecular substances including 
salts, and then the retentate was freeze-dried. Moreover, since cold-alkali extraction 
would give sparingly water-soluble polysaccharides, micronisation techniques can be 
applied to reduce the particle size, decrease the bulk density, and improve the water 
solubility of the polysaccharides extracted (Chau et al., 2006; Lai, 2008). 
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1.2.3 Structure-Activity Relationship (SAR) of mushroom polysaccharides 
Mushroom polysaccharides are a class of macro-molecules, which differ greatly 
in their chemical structures and demonstrate various biological activities (Table 1.1.) 
(Wasser, 2002). They may have a structure ranging from homopolymers to highly 
complex heterpolymers. The primary structure of a polysaccharide is defined by its 
monosaccharide composition, glycosidic linkages, molecular weight, as well as the 
degree, property and location ofbranching groups. These factors would influence 
the biological activities of the mushroom polysaccharides (Zhang et al., 2007). 
Monosaccharides found in mushroom polysaccharides include glucose, 
galactose, mannose, xylose, arabinose, fucose, ribose, and glucuronic acid. The 
monosaccharides are linked by either a- or P_glycosidic bonding at different 
positions (Zjawiony, 2004; Zhang et al.，2007). Among these linkages, it is 
suggested that a p(l,3)-linked backbone (Figure 1.9), called P-D-glucan, is one ofthe 
important structural features for the potent biological activities of mushroom 
polysaccharides. In contrast, p-glucans with p( 1,6)-linked backbone have less 
bioactivity. (Herre et al., 2004; Mizuno et al., 1995; Zhang et al., 2007). 
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Table 1.1 : Selected Medicinal Mushrooms with p-glucans as Active Components 
(modified from Chan et aL, 2009) 
Herbs Common Name p-glucan structure Types of p-glucans 
Lentinus edodes Shiitake mushroom P-1,3； 1,6-glucan Lentinan 
Schizophyllan Brazilian mushroom, f>-1,3 ； 1,6-glucan Schizophyllan (SPG) or 
commune Schizophyllan sizofiran 
Grifolafrondosa Maitake mushroom P-1,3; 1,6-glucan Maitake D-Fraction 
with xylose and 
mannose 
Coriolus versicolor YunZhi Protein bound PSP (polysaccharide 
P-1,6-glucan peptide), PSK 
^)olysaccharide-Kureha 
or polysaccharides -K, 
krestin) 
Ganoderma lucidum Lingzhi, Reishi P-1,3; 1,6-glucan Ganoderma 
polysaccharides, 
•: Ganopoly 
Agaricus blazei Brazilian Protein bound Agaricus 
sun-mushroom, P-l,6-glucan polysaccharides 
Himematsutake 
mushroom 
Pleurotus ostreatus Oyster mushroom, P-l,3-glucan with Pleuran 
ping gu galactose and 
mannose 
Coprinus comatus Shaggy ink cap, P_ 1,3 -glucan Coprinus 
lawyer's wig, or polysaccharides 
shaggy mane 
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Figure 1.9 : The structure of fungal P-D-glucans (adapted from Herre et al., 2004) 
Other than existed as a linear form, mushroom polysaccharides can have 
branches in which the backbone would attach to various carbohydrate or 
non-carbohydrate groups at different positions. Some mushroom polysaccharides 
are attached with proteins or peptides as a polysaccharide-protein or 
polysaccharide-peptide, which have also been demonstrated to exert a potent 
antitumor property. The frequency of occurrence of branching in the backbone is 
called degree ofbranching (Yadomae and Ohno, 1996)，which is another important 
factor that determines the immunomodulatory activity of mushroom polysaccharides. 
An optimum degree ofbranching is critical for biological activities of mushroom 
polysaccharides. It is recommended that the most active mushroom 
polysaccharides should have a degree ofbranching between 0.20-0.33 (Bohn and 
BeMiller，1995). Branching could be chemically modified to an optimal degree, 
resulting in a higher bioactivity (Sasaki and Takasuka, 1976; Chihara et al., 1970; 
Narui etal., 1980). 
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Different extraction methods can isolate mushroom polysaccharides with 
different conformation which is critical to determine their bioactivities. There are 
three types of secondary structures: single helix, triple helix, and random coil. It is 
suggested that a triple-helical conformation of P(l,3)-linked glucans is important for 
their immunostimulatory activity (Wasser, 2002), and only high molecular weight 
fraction (more than 90,000 Da) form triple helical structures (Saito et al., 1977and 
1991), but linear P(l,3)-linked glucan with intermediate chain length and p-glucans 
with low molecular weight are random coil in aqueous solution with less bioactivity 
(Yadomae and Ohno, 1996). Also, large molecular weight P-glucans of mushroom 
polysaccharides have been demonstrated to be more potent than those of low 
molecular weight. The possible reason is that they would act as a more effective 
ligand for stimulation of surface receptors (Bohn and BeMiller, 1995; Brown and 
Gordon 2003). 
1.2.4 Previous studies on immunomodulatory effects of mushroom sclerotial 
polysaccharides 
Production of mushroom sclerotium is an effective strategy for survival of 
Ascomycetes and Basidiomycetes under undesirable conditions where mushrooms 
nter the dormant phase of the life cycle and produce mushroom sclerotia (Carlite et 
a l , 2001 ； Stamets, 1993 ； Wasser and Weis, 1999). Mushroom sclerotium is a 
compact mass ofhardened mycelium with spherical in shape ranging from a 
millimeter to a centimeter in diameter (Carlite et al，2001). The outer thickened 
and wood-like textured wall consists of dead cells impregnated with melanin. The 
inner part is nutrient-rich with abundant lipid and glycogen reserve to help the 
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mushrooms to overcome the undesirable conditions (Carlite et al., 2001; Hoffman, 
1999). This is possibly the reason why mushroom sclerotium is a richer source of 
polysaccharides when compared with fruiting body. 
Polyporus rhinocerus (PR) is a novel mushroom sclerotium under the family of 
Polyporacea. To obtain PR sclerotium, the yellowish-brown mycelium was 
inoculated and cultivated on potato dextrose agar (PDA) plate, following by three to 
five months of growing in an incubator (Lai, 2005; Lai, 2008). Previous studies of 
the polysaccharides extracted from this mushroom sclerotium in our lab had shown 
that the hot-water fraction were found to be protein-containing polysaccharide, while 
the cold-alkali sonication fraction to be pure glucan which in turn contributed to the 
remarkable immunomodulatory and antitumor properties (Chau et al., 2007; Gao et 
al., 2009; Lai, 2005; Lai, 2008). The hot-water fraction exerted direct cytotoxic 
effect on various human tumor cell lines, especially HL-60 cell line (Lai, 2005). 
Cell cycle analysis revealed that there was the onset of apoptosis and cell cycle arrest 
at Gi phase of the HL-60 cell line after treatment ofhot-water extracted PR 
polysaccharide (Lai, 2005). Moreover, in vivo study model, PR polysaccharides 
possessed notable host-mediated antitumor activity on the Sarcoma 180 implanted 
BALB/c mice (Lai, 2005). They also stimulated the enlargement of spleen in both 
healthy BALB/c mice and healthy athymic nude mice, the activation of those 
immune cells belonging to the innate immunity, up-regulation of macrophage 
inflammatory proteins in the serum level, and reduction of tumor size in athymic 
nude mice with HL-60 xenografts due to the infiltration ofF4/80+ macrophages, 
after injected PR polysaccharides intra-peritoneally (Lai, 2005; Lai, 2008). 
Real-time mRNA studies of the murine spleen have indicated that the possible 
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receptors involved were mainly of toll-like receptor type rather than CR3 or Dectin-1 
for in vivo immunomodulatory studies, but which is contradictory to the results of in 
vitro studies (Lai, 2005; Lai. 2008)，and needs fiuther investigation . 
1.3 Recognition of p-glucan by specific receptors 
In fact, P-glucans are only found in fungi, plants and some bacteria, and never 
found in animals, and thus they are considered as highly conserved 
pathogen-associated molecular patterns (PAMPs) which are recognized by 
germline-encoded pattern-recognition receptors (PRRs) of the innate immunity. 
PRRs are expressed on monocytes, macrophages, polymorphonuclear leukocytes, 
DCs, and Natural killer (>IK) cells. Unlike the receptors of the adaptive immunity 
undergoing somatic mutation, PRRs use a conserved mechanism ofhost defense to 
recognize pathogens (Brown, 2006; Herre et aL, 2004). 
PRRs can be divided into three groups depending on their locations: serum or 
tissue fluids, membrane bound, and intracellular. Because of their high molecular 
weight, P-glucans in zymosan cannot directly penetrate into the innate immune 
effecter cells to initiate the immune responses. They are recognized either directly 
by non-opsonic PRRs at the membrane of the effecter cells in the innate immunity, or 
indirectly by serum or tissue-fluid opsonins, such as complements, coating the 
P-glucan particles allowing recognition by opsonic PRRs, leading to uptake and 
breakdown of the P-glucan particle, and also induction of inflammatory responses 
(Figure 1.10) (Brown, 2006; Herre et al., 2004). 
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Figure 1.10 : Methods ofpathogen recognition by pattern-recognition receptors 
(adapted from Brown, 2006). 
Several P-glucan receptors have been discovered: Complement Receptor 3 (CR3), 
Lactosylceramide, Scavenger receptor family, and Dectin-1 (Figure 1.11) (Herre et 
al，2004; Chan et al, 2009). Only CR3 and Dectin-1 would be discussed below, 
and toll-like receptor 2 (TLR2), a well-known PRR, would also be reviewed. 
(Brown & 
Gordon (R>ce and others 2002) 
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Figure 1.11 : Macrophage fungal P-glucan PRRs (modified from Herre et al, 2004) 
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1.3.1 Complement Receptor 3 (CR3) 
1.3.1.1 Introduction of CR3 
CR3 was discovered by Ross and others in 1987. It expresses on neutrophils, 
monocytes, NK cells, macrophages, and DCs (Yan et al., 1999a and 1999b). CR3 is a 
membrane bound PRR ofheterodimeric glycoprotein. It belongs to the p2-integrin 
family. CR3 consists of a aM (CDllb) chain non-covalently linked with a p2 
(CD18) chain, and thus is also called aMp2-integrin or CDllb/CD18 (Figure 1.12) 
(Linehan et al.,2000). 
/ < " " l x 
/ cd11b ^/cd18 \ 
cpcp99^9cpcp99999^ggg9 
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cxxDor ooooo666r cxxx> 
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Figure 1.12 : Schematic representations of complement receptor 3 (CR3). a, 
a-integrin subunit; p, P-integrin subunit. (Adapted from Linehan et aL, 2000) 
1.3.1.2 Expressions of CR3 to recognize fungi 
Complement 3 (C3) is a major molecule involved in the amplification step of 
complement activation system which have various function in innate immunity 
including lysis of target cells, opsonization of antigens for phagocytosis or 
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endocytosis, activation of inflammatory responses, clearance of immune complexes 
by cells in the liver and spleen (Figure 1.13) (Kindt et al., 2007). 
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Figure 1.13 : The multiple uses of the complement system (adapted from Kindt et al., 
2007) 
It is subsequently cleaved to C3b and C3a by C3 convertase upon activation. 
For regulation of the Complement system, C3b is finally undergone Factor 
I-mediated cleavage to the inactivated complement 3b (iC3b) which is a very stable 
fragment to inactivate various complement system (Figure 1.14). iC3b fragments 
can still act as an opsonin to bind on the surface of the reactor cells, and thus 
opsonise the targets. CR3 could recognize iC3b-coated targets, acting as an opsonic 
receptor for recognition of opsonized glycoconjugates (Ehlers, 2000). A lectin 
domain in CR3 mediates P-glucans recognition and regulates cellular adhesion, and 
thus this facilitates phagocytosis of target substances. LPS stimulation at high dose 
could lead to upregulation of the iNOS and increase NO production (Matsuno et al., 
1998). However, CR3-mediated phagocytosis alone does not induce ROS 
production (Wright and Silverstein, 1982), and production ofIL-12 and other 
proinflammatory cytokines (Brown, 2006; Ross et ai, 1999; Vetvicka et al., 1996; 
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Ymet al, 1999a and 1999b) 
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Figure 1.14 : Inactivation ofbound C3b by Factor I of complement system (adapted 
from Kindt et al., 2007) 
1.3.2 Dectin-1 
1.3.2.1 Introduction of Dectin-1 
The name "Dendritic-cell-associated C-type lectin-l" (Dectin-1) was used 
because Dectin-1 was originally thought to be a dendritic cell surface specific 
receptor recognizing an endogenous ligand on T cells by using a subtractive cDNA 
cloning (Ariizumi et al，2000). Later on, it was re-identified as the major receptor 
(PRR) specific for soluble or particulate P-glucans, but not monosaccharides or other 
carbohydrates with different linkages, in NIH3T3 cells expressing Dectin-1 (Brown 
and Gordon, 2001). By way of P-glucans specificity, binding ofFITC-labeled 
zymosan, in addition to intact Saccharomyces cerevisiae and Candida albicans in 
Dectin-1 expressing NIH3T3 cells and bone-marrow-derived macrophages (BMDM) 
were blocked by specific inhibitors (laminarin and glucan phosphate) against 
dectin-1 (Brown and Gordon, 2001; Brown et al., 2002). 
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The gene encoding dectin-1 is located on Chromosome 12 in humans and 
Chromosome 6 in mice (Ariizumi et al，2000; Brown, 2006). It is one of the 
members of NK-cell-receptor-like C-type lectin cluster found in the NK complex 
(Figure 1.15). Dectin-1 is the first type of NK-cell-receptor-like C-type lectin 
whose major ligand is a polysaccharide, P-glucans. (Brown, 2006). 
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Figure 1.15 : Genomic localization within the myeloid-cell-expressed 
NK-cell-receptor-like C-type lectin cluster (Brown 2006) 
Dectin-1 is highly expressed on monocytes, macrophages, DC cells, and 
neutrophils (Brown and Gordon, 2001; Taylor et al., 2002), and a subset o fT cells 
(Ariizumi et al., 2000). In humans, it is also expressed on B cells and eosinophils 
(Willment et al，2001). Dectin-1 is not found in all tissues, but highly expressed in 
lung and intestine which are considered as portals of pathogen entry. It has the 
potential function in constant immune surveillance (Brown and Gordon, 2001). In 
mice, expression ofdectin-1 can be influenced by various cytokines, steroids and 
microbial stimuli. For instance, Interleukin-4 (IL-4), and IL-13 could obviously 
increase expression of dectin-1, while IL-10, Lipopolysaccharides (LPS) and 
dexamethasone could inhibit expression of dectin-1 (Brown and Gordon, 2003; 
Brown, 2006; Dennehy and Brown, 2007). 
‘ -25-
1.3.2.2 Structure of Full-length Dectin-1 
Dectin-1 is a type II transmembrane protein (Figure 1.16). The structure of 
full-length dectin-1 protein consists of a C-terminal extracellular domain, a 47 amino 
acids transmembrane stalk region, and a 40 amino acids N-terminal intracellular 
domain. The extracellular domain is a single C-type lectin-like domain which is 
also called Carbohydrate recognition domain (CRD). A stalk region connected 
CRD to the transmembrane domain. The cytoplasmic tail has an immunoreceptor 
tyrosine-based activation motif (ITAM)-like motifbut which is not conformational to 
the conventional ITAM consensus, YxxL/Ix6-12YxxL/I. The N-terminal tyrosine 
(tyrosine-3) resides in an YxxxL rather than an YxxL sequence. There are two 
N-linked glycosylation sites in the CRD in mice, whereas there is only a single site in 
the stalk region in humans (Brown, 2006; Willment et al., 2001; Heinsbroek et al., 
2006; Kato et aL, 2006; Underhill, 2007). 
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Figure 1.16 : Full-length Dectin-1. Mouse: Two N-linked glycosylation sites in the 
CRD (red); Human: A single N-linked glycosylation site in the stalk region (blue). 
ITAM : Immunoreceptor tyrosine-based activation motif, (adapted from 
Brown,2006) 
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In the conventional ITAM signaling, after ligands binding, the ITAM dual 
tyrosines are phosphorylated by Src family kinases, then spleen tyrosine kinase (syk) 
is recruited and interacted with the dual phosphotyrosines via their dual SH2 
domains (Figure 1.17). However, mutation of the membrane proximal tyrosine 15 
eradicated its signaling, while mutation of the membrane distal tyrosine 3 does not 
affect Dectin-1-mediated response. It suggests that unlike the conventional ITAM 
signaling, a single ITAM tyrosine phosphorylation might be sufficient to recruit Syk 
to Dectin-1 (Taro and Akira, 2009; Tohyama and Yamamura, 2009). 
Spleen tyrosine kinase (Syk) 
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Figure 1.17 : Schematic representation of domain structure of Syk. N-SH2 and 
C-SH2 indicate Src homology 2 (SH2) domains located in tandem. lnterdomain A 
locates between N-SH2 and C-SH2 domains and interdomain B locates between 
C-SH2 and the kinase domain, (adapted from Tohyama and Yamamura, 2009) 
After spleen tyrosine kinase (syk) was phosphorylated, Caspase recruitment 
domain 9 (CARD9) linked this signal to the B-cell CLL/lymphoma 10 
(Bcl 10)-Mucosa-Associated Lymphoid Tissue 1 (MALT1) complex which led to 
Nuclear factor-kapper B ^4F-KB) activation, and thus produce inflammatory 
cytokines, such as TNF-alpha, IL-2 and IL-10, under zymosan stimulation (Gross et 
a/. ,2006). 
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1.3.2.2.1 Isoforms of Dectin-1 in Mice 
In mice, reverse-transcription-PCR analysis shows that two isoforms of dectin-1, 
Dectin-lAand Dectin-lB, are differentially expressed by various mouse strains 
(Figure 1.18A). The Dectin-1A is a full-length protein, while the Dectin-1B has a 
much shorter stalk region (Figure 1.18B) (Heinsbroek et al, 2006). The expression 
levels oftwo functional isoforms in mice are temperature-dependent. Dectin-lAis 
expressed almost equally at 4, 25，30 and 37°C, while the expression ofDectin-lB is 
increased with increasing temperature (Heinsbroek et al, 2006).‘ 
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Figure 1.18 : (A) Reverse Transcription-PCR analysis of Tg peritoneal macrophage 
from different mouse strains. Plasmids containing dectin-1A and dectin-1B were 
used as positive controls. Water was used as a negative control. (B) Schematic 
representation of the dectin-l-encoded peptides (adapted from Heinsbroek et al., 
2006). 
1.3.2.2.2 Isoforms of Dectin-1 in Humans 
In humans, dectin-1 is called P-glucan receptor (PGR), and two major and six 
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minor splice isoforms of pGR have been cloned (Willment et al., 2001) (Figure 1.19). 
Only the two major isoforms, namely P-glucan receptor A (j3GR-A) and P-glucan 
receptor B (PGR-B) are functional, as other isoforms have incomplete CRD, CRD 
with insertion, deletion of transmembrane domain, or premature stop codon (Yokota 
et al., 2001). pGR-A is a full-length dectin-1 protein, whereas pOR-B is a truncated 
dectin-1 protein which has no stalk region (Willment et aL, 2001 ； Yokota et al, 
2001). Like isoforms in mice, the two functional isoforms in humans are expressed 
at different temperatures. FITC-labeled zymosan recognition of Dectin-1 
transduced NIH-3T3 cells was temperature-dependent. Dectin-1A expressed at 4 
and 3TC. But Dectin-lB almost expressed only at 37°C but little at 4 � C 
(Heinsbroek et al., 2006). 
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Figure 1.19 : Cartoon structures ofhuman Dectin-1 (adapted from Herre et al., 2004) 
1.3.2.3 Immune responses triggered by of Dectin-1 
Various studies showed that dectin-1 mediated several immune responses to 
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zymosan (Figure 1.20). After dectin-1 bound zymosan, it could induce endocytosis 
/ phagocytosis in DC cells and macrophages to uptake p-glucans (Brown et al.，2003; 
Brown and Gordon, 2003; Brown, 2006; Chan et al” 2007; Dennehy and Brown, 
2007; Moradali et al，2007; Underhill, 2007). It could stimulate respiratory burst in 
macrophage to break down the p-glucans by ROS (Saijo et al., 2007; Tayor et al., 
2007). 
Moreover, dectin-1-mediated recognition of zymosan could trigger intracellular 
signaling pathways to activate nuclear transcription factor, and thus induce the 
production of inflammaotry cytokines and chemokines. It could induce numerous 
cytokines and chemokines such as IL-12, Tumor-necrosis factor-a (TNF-a), IL-6, 
IL-10, and IL-23, in both DC cells and macrophages. It also triggers 
CXC-chemokine ligand 2 (CXCL2), which in turn lead to recruitment and activation 
of other immune cells, such as T cells and neutrophils. The induction of IL-12 and 
TNF-a might require the collaboration with Toll-like receptor 2 (TLR2), since these 
responses are severely reduced in TLR2-deficient macrophages (Brown, 2006; Chan 
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Figure 1.20 : Dectin-1-mediated cellular responses to zymosan (modified from 
Brown et a/.,2003). 
1.3.3 Toll-like 2 receptor (TLR2) 
1.3.3.1 Introduction of TLR2 
In 1980s，Germany researchers found that the protein Toll was involved in fruit 
fly development. In 1996，Hoffmann and Lemaitre discovered that Toll-deficient 
Drosophila exhibited high susceptibility to lethal infection with Aspergillus 
fumigates (Hoffmann, 2003； Lemaitre et al.，1996). Subsequently, in 1997， 
Medzhitov and Janeway identified a human homologue ofToll which activated the 
expression of innate immune responses including production of inflammatory 
cytokines and expression of co-stimulatory molecules, and mutant lps gene encoded 
a mutant form of a TLR in mouse strains that fail to promote innate immune 
responses against bacterial LPS (Medzhitov et al., 1997). TLRs are highly 
conserved between invertebrate and vertebrate, serve as PRRs to recognize a wide 
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range ofPAMPs, and play an important role in triggering innate immune responses. 
Up to now, a family of membrane-bound TLRs, TLR1 to TLR13, has been identified 
in mammals (Figure 1.21) (Kindt et al., 2007). TLRs that recognize extracellular 
ligands such as LPS and zymosan localized in the plasma membrane, while TLRs 
that interact with intracellular ligands such as DNA and RNA exist in the intracellular 
membrane. They form dimers with other TLRs or itself. 
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Figure 1.21 : Toll-like receptors (TLRs) and their ligands (adapted from Kindt et al., 
2007) 
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Among them, TLR2 is the well characterized TLRs. It has been found that 
TLR2 was recruited to phagosomes containing zymosan in macrophage (Ozinsky et 
al., 2000). Expression of dominant negative TLR2 or dominant negative MyD88 
could suppress the inflammatory responses triggered by macrophage. It has been 
shown that TLR2 is one of the main receptors for pathogenic fungi, including 
Saccharomyces cerevisiae, and Aspergillus fumigates (Lemaitre et al., 1996; 
Underhill et al.，1999). It is important to note that other TLRs, such as TLR4, have 
been also involved in fungal recognition. TLR2 are expressed on the cell surface, 
and recognize a wide range of ligands including zymosan from fungi (Akira et al.， 
2006). 
1.3.3.2 Structure of TLR2 
TLR2, sharing a common structure with other TLRs, is a transmembrane protein 
composed of three major domains, including an extracellular region, a 
transmembrane domain, and an intracellular domain (Figure 1.22). The 
extracellular region which is responsible for ligands binding and recognition, consists 
of repeating motifs of Leucine-rich repeat (LRR) which contains 24-29 amino acids 
with the sequences 'xLxxLxLxx' as well as ‘xOxxOxxxxOxxLx‘ (0 : hydrophobic). 
The intracellular domain is known as Toll/IL-lR (TIR) domain, since it is 
homologous to the comparable region of a receptor for Interleukin-1, required for 
initiating downstream signaling pathways. Three highly conserved sequences of 
amino acids called box 1, 2, and 3 in TIR domain are important for the interaction of 
domain effectors in the TLR signal-transduction pathway (Jin and Lee, 2008; Kindt 
et al, 2007). 
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Figure 1.22 : Structure of a toll -like receptor (TLR) (adapted from Kindt et al., 
2007) 
1.3.3.3 Immune responses triggered by TLR2 
TLR2 is not sufficient to trigger phagocytosis of zymosan (Gantner et al, 2003)， 
but it could affect the efficiency of phagocytosis by affecting the protein expression 
and signaling transduction during phagocytosis. Moreover, upon stimulation with 
zymosan, TLR2 did not stimulate ROS production in BMDM. There were no 
significant differences between wild-type and TLR2-deficient BMDM in ROS 
response (Gantner et al., 2003). 
For the production ofRNS, there are few studies to investigate whether it is a 
TLR2-dependent event triggered by zymosan or mushroom polysaacharides. But 
several groups of researchers have demonstrated that macrophages produce higher 
levels ofnitric oxide 0^0) upon activation ofbacterial ligands such as LPS, 
mediated by TLR2 (Arko-Mensah et a!., 2007; Janeway et al., 2005; Kindt et al., 
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2007; Marcato et al., 2008). As shown in the above, TLR2 might collaborate with 
Dectin-1 to detect fungi and trigger cytokines production, including IL-12 and 
TNF-a, upon zymosan stimulation (Gantner et al，2003). TLR2 requires CD14 as a 
co-receptor, so as to initiate signaling upon recognition of ligands (Wetzler, 2003). 
1.4 Research Objectives 
Previous studies have shown that the polysaccharides of this novel mushroom PR 
had remarkable host-mediated antitumor activity and notable direct cytotoxic effect 
on various human tumor cell lines, and stimulated macrophage migration and 
inflammatory proteins secretion (Gao and Cheung, 2009; Lai, 2005; Lai, 2008). 
But their immune responses on antigen-presenting cells (APCs) have not been 
extensively investigated. Moreover, the studies of their immunomodulatory 
effects through cell surface P-glucan receptors were incomplete. Most of the other 
studies on P-glucan receptors were only limited to the yeast-derived P-glucan 
particulate, zymosan but was not on edible and medicinal mushroom polysaccharides. 
Therefore, this study aims to investigate in the immunomodulatory effects of PR 
polysaccharides on APCs as well as the mechanisms ofhow the PR polysaccharides 
act on via P-glucan receptors to exert such immunomodulatory effects. This 
would provide a new viewpoint for understanding the underlying mechanism of the 
immunomodulating and antitumor effects triggered by mushroom polysaccharides in 
terms of cell surface receptor-type interaction. In general, the approaches used in 
this project were as follows: 
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(a) In vitro studies: To investigate and compare the activation ofhuman monocytic 
leukemia-derived cell line, THP-1 treated with PR polysaccharides extracted by 
different methods including hot-water fraction (PRW) and micronization 
associated cold-alkaline-sonication fraction (mPRSon). Parameters of 
activation and methods of their determination (in parenthesis) include: 
(i) General effects of proliferation / inhibition (MTT cell proliferation assay 
and BrdU cell proliferation assay) 
(ii) Cell surface markers (flow cytometry using the corresponding antibodies) 
(iii) Cell morphology (phase-contrast microscopy) 
(iv) Phagocytosis (flow cytometry using fluorescence-labelled dextrans) 
(v) Release of ROS (flow cytometry using 2',7'-Dichlorofluorescin diacetate) 
(vi) Release of RNS (Gresis reagents test) 
(vii) Secretion of cytokines to culture medium (human cytokine profile array) 
(b) Ex vivo studies: To investigate and compare the activation of mouse primary 
bone-marrow-derived (myeloid type with surface CDllcexpression) immature 
dendritic cells, immature BMDCs treated with PRW and mPRSon. Parameters 
of activation and methods of their determination (in parenthesis) include: 
(i) General effects of proliferation / inhibition (MTT cell proliferation assay) 
(ii) Cell surface markers (flow cytometry using the corresponding antibodies) 
(iii) Cell morphology (phase-contrast microscopy) 
(iv) Endocytosis (flow cytometry using fluorescence-labelled dextrans) 
(v) Release of RNS (Gresis reagents test) 
(vi) Secretion of cytokines to culture medium (mouse cytokine profile array) 
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(c) Identifying cell surface P-glucan receptors at the protein level: the expression 
levels of those previously identified cell surface p-glucan receptors, including 
Dectin-1, CR3 and TLR2 on human monocytes/macrophages and murine 
dendritic cells were examined by flow cytometry using their corresponding 
antibodies. 
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Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 Mushroom sclerotia 
Sclerotia of Polyporus rhinocerus were supplied by the Sanming Mycological 
Institute in Fujian, China (Fig. 2.1). The sclerotia were peeled and milled into 
powder by a mechanical grinder (MF10, IKA) through a 0.5 mm sieve. 
H^^^^^HI^  
Figure 2.1 The sclerotia of Polyporus rhinocerus [PR](虎乳靈芝） 
2.1.1.1 Polysaccharide extraction from mushroom sclerotia 
PR mushroom sclerotial powder was subjected to the following protocols 
developed in our laboratory as previously described (Lai et al., 2008; Zhang et al, 
2004). Before extraction, PR mushroom sclerotial powder was firstly micronized, 
according to the method described previously (Chau et al.，2007). The PR sclerotial 
powder was micronized first with a Crude Grinder (Rong Tsong Iron Works 4, RT-04, 
Taiwan) and then followed by a ball-mill machine (PM100, Retsch, Germany). In 
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brief, the PR sclerotial powder was firstly grinded up by the Crude Grinder for 
different periods of time in accordance with different particle size requirements. 
After that, the powder was mixed with agate balls (D = 3.0 mm) at a ratio of 1:1 (VAV, 
-170 mL for each) in a 500 mL agate grinding bowl and ground for 5-15 hours to 
achieve different particle sizes at a rotary speed of 400 rpm. At each time, the 
micronized PR sclerotial powder powder (mPRSon) was sampled and measured 
particle sizes using a scanning electron microscope (Motic BA 300 equipped with 
Moticam 2000) plus the software (Motic Image, Version 2.0 ML) until the PR 
sclerotial powder for extraction reached particle sizes of 10 -20 ^m. 
For sonication-assisted cold alkaline extraction, the micronized PR mushroom 
sclerotial powder was soaked in 1 M cold sodium hydroxide with a 
sample-to-solvent ratio of 1: 20 (w/v, g/mL) for 48 hours at room temperature. 
Then this mixture was neutralized with hydrochloric acid and sonicated with a 
sonication probe for 30 minutes (Sonics, VCX600). The mixture was then 
centrifUged at 10000 rpm at 4°C for 30 minutes. The supernatant was subjected to 
dialysis using dialysis membranes (MWCO: 6000-8000Da, Spectray^or， 
SPECTRUM) until the total dissolved solutes (TDS) was below 10 by TDS detector. 
The sonication-assisted cold alkaline extracts were lyophilized by a freeze-drier and 
named as PRSon for micronization described in the above until they reached particle 
sizes of 50 i^m (Figure 2.2 A) and 30 i^m (Figure 2.2 B). 
For hot-water extraction, the micronized PR mushroom sclerotial powder was 
kept in water at 95-100"C for 3 hours with stirring, with a sample-to-solvent ratio of 
1:25 (w/v, g/mL). After cooling, the mixture was centrifuged at 10000 rpm at 4°C 
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for 30 minutes. The whole extraction process was repeated twice to obtain a total 
of three fractions. These three fractions were combined into a single fraction which 
was dialyzed using dialysis membranes (MWCO: 6000-8000Da, Spectray^or, 
SPECTRUM) until the TDS was below 10. The hot-water-soluble extracts were 
lyophilized by a freeze-drier and named as PRW for later use. 
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Figure 2.2 : The micronized PRSon (mPRSon) shown under scanning electron 
microscope (A) 50 i^m, (B) 30 p_m. 
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2.1.2 Antibodies and reagents 
Antibodies for human were used: Phycoerythrin (PE)-conjugated mouse 
anti-human CD14 monoclonal antibody (mAb) (clone M5E2, Cat.#555398), 
PE-conjugated mouse anti-human CDllb/Mac-1 mAb (clone ICRF44, Cat.#555388), 
fluorescein isothiocyanate (FITC)-conjugated mouse anti-human HLA-DR mAb 
(clone TU36, Cat.#555560) were purchased from BD Pharmingen (Heidelberg, 
Germany). PE-conjugated mouse IgGlK (Cat.#555749) and IgG2aK (Cat.#555574) 
mAbs, and FITC-conjugated mouse IgG2bK (Cat.#555742) mAb were used as 
isotype control. Purified mouse anti-human CD282/TLR2 mAb (clone 383936， 
Cat.#MAB2616, 0.5 mg/mL, 1:20), and purified mouse anti-human 
Dectin-l/CLEC7AmAb (clone 259931, Cat.#MAB1859, 0.5 mg/mL, 1:20) as 
primary antibodies, and purified mouse IgG2b mAb (clone 133303, Cat#MAB0041, 
0.5 mg/mL, 1:20) used as isotype control were purchased from R&D systems, Inc 
(Minneapolis, MN 55413). FITC-conjugated goat anti-mouse IgG/IgM polyclonal 
antibody, pAb (Cat.#555988, 0.5 mg/mL, 1:20) purchased from BD Pharmingen 
(Heidelberg, Germany) was used as secondary antibody. 
Antibodies for mouse were used: Phycoerythrin (PE)-conjugated hamster 
anti-mouse CDl lc mAb (clone HL3, Cat.#553802, 0.2 mg/mL, 1:3), PE-conjugated 
rat anti-mouse CD40 (clone 3/23, Cat.#553791, 0.2 mg/mL, 1:3), PE-conjugated 
hamster anti-mouse CD80 (clone 16-lOAl, Cat#553769, 0.2 mg/mL, 1:3), 
PE-conjugated rat anti-mouse CD86 (clone GL1, Cat.#553692，0.2 mg/mL, 1:3)， 
PE-conjugated rat anti-mouse I-Ad/I-Ed (clone 2G9, Cat.#558593，0.2 mg/mL, 1:3)， 
PE-conjugated rat anti-mouse CD4 (clone RM4-5, Cat.#553049，0.2 mg/mL, 1:3)， 
and, PE-conjugated rat anti-mouse CD8a (clone 53-6.7, Cat.#553033，0.2 mg/mL, 
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1:3) were purchased from BD Pharmingen (Heidelberg, Germany). PE-conjugated 
rat IgG2aK (Cat.#553930, 0.2 mg/mL, 1:3) mAb，and PE-conjugated hamster IgGRl 
(Cat.#553954, 0.2 mg/mL, 1:3) and IgG2K (Cat.#550085 , 0.2 mgAnL，1:3) mAbs 
were used as isotype control. Alexa Fluor®488 (AF488)-conjugated rat anti-mouse 
CD282/TLR2 mAb (clone 6C2, Cat.#MCA2266A488), PE-conjugated rat 
anti-mouse CDllb/Mac-1 (clone 259931, Cat.#MCA711PE), and PE-conjugated rat 
anti-mouse Dectin-l/CLEC7AmAb (clone 2A11, Cat.#MCA2289PE) were 
purchased from AbD Serotec (Oxford, UK). PE-conjugated rat IgG2b 
(Cat.#MCA1125PE), andAF488-conjugated rat IgG2a (Cat.#MCA1212A488) mAbs 
were used as isotype control. 
Recombinant mouse granulocyte macrophage-colony stimulating factor, 
rmGM-CSF (Cat. # PMC2015), and recombinant mouse Interleukin-4, rmIL-4 (Cat. 
# PMC0045) were purchased from Invitrogen. FITC-labeled dextran, FITC-DX 
(average molecular weight 40kDa, Cat#FD40S), and 2',7'-Dichlorofluorescin 
diacetate, DCFH-DA, >97% (Cat.#D6883) were purchased from Sigma (United 
Stated). 
2.1.3 Human acute leukocyte monocytic cell line and culture medium 
The human monocytic leukemia-derived cell line, THP-1 (TIB-202, ATCC; 
American Type Culture Collection) was maintained in Roswell Park Memorial 
Institute-1640 medium, RPMI-1640 (Cat. # 31800-022，GIBCO), supplemented with 
0.05 mM 2-mercaptoethanol (Cat. # 21985-023, GIBCO), 1 mM sodium pyruvate 
(Cat. # S8636, Sigma) and 10% [volume/volume (v/v)] fetal bovine serum, FBS (Cat. 
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# CH30160.03，HyClone), 1% penicillin-streptomycin (Cat. # SV30010, HyClone), 
and adjusted to pH 7.2 with the addition o f l . 5 g/L sodium bicarbonate, then filtered 
by 0.22 i^m durapore® membrane filters (Cat.# GVWP04700, Millipore). The cells 
were seeded at a concentration ranged from 2 x 10^ to 5 x 10^ cells/mL, cultured in 
tissue culture flasks (NUNC) and incubated at 37°C in a humidified atmosphere of 
5% of CO2. The cultures were maintained with replacement of fresh medium at 
48-hour interval during subculture. 
2.1.4 Preparation of murine bone marrow-derived immature dendritic 
primary cells (immature BMDCs) 
Immature BMDCs preparation was adopted from a previously described method 
with minor modification (Lutz et al., 1999; Son et al., 2002). Seven- to 
nine-week-old male BALB/c mice were purchased and housed in the animal house of 
the Chinese University ofHong Kong. 
Primary mouse bone marrow cells were collected from femurs and tubuas of 
mice, and cell suspension made by flushing bone marrow using 25 needle syringe 
and cold IX phosphate buffer saline (IX PBS) and transferred into 50 mL tubes. 
The cell suspension was washed by IX PBS. Ten milliliters of red blood cell lysis 
buffer was added into the cell suspension to lysze the red blood cells, and then 
washed by IX PBS. The cells were cultured into culture flask at a concentration of 
1 X 10^ in complete media (RPMI-1640 media supplemented with 50 jiM 
2-mercaptoethanol, 10% heat-inactivated FBS, 1% penicillin-streptomycin, 50 
ng/mL rmGM-CSF, and 50 ng/mL rmIL-4), in a humidified incubator at 5% CO2 and 
- -43-
37°C. On day 3, 10 mL of extra complete media was added into the flask. On day 
5, 90% of the media was replenished with fresh complete media. On day 7，the 
culture cells were regarded as immature bone-marrow-derived dendritic cells 
(immature BMDCs) with >75% positive expression of CDllc as measured by CXP 
500 flow cytometer (Figure 2.3) (Beckman Coulter, Miami, FL). 
Bone marrow cells Bone-marrow<terived immature dendritic cells 
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Figure 2.3: Flow cytometric analysis of murine myeloid immature BMDCs by (A) 
DC surface marker CDl lc expression on bone marrow cells immediately isolated 
from femurs and tibias. (B) DC surface marker CDllc expression after bone 
marrow cells were incubated with 50 ngAnL granulocyte-macrophage-colony 
stimulating factor (GM-CSF) and 50 ng/mL interleukin-4 (IL-4) for 7 days. 
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2.2 Methods 
2.2.1 Chemical Analysis 
2.2.1.1 Measurement of monosaccharide profile 
2.2.1.1.1 Acid depolymerisation 
The method was modified from previous studies (Lai, 2008). About 15 mg 
of sample was hydrolyzed with 0.7 mL of 12 M concentrated sulfuric acid at 35°C 
for 60 min with continuous stirring. The mixture was diluted to 2 M sulphuric acid 
by addition of3.5 mL distilled water, and the mixture was heated in a boiling water 
bath for 60 min. The hydrolysate was cooled to room temperature. 
2.2.1.1.2 Neutral sugar derivatization 
Three milliliters of hydrolysate was transferred to a new test tube and internal 
standard allose (1 mL, 1 mg/mL; Fluka, CatJ05750) was added. The pH of the 
hydrolysate was adjusted to alkaline by addition of 12 M ammonia. Five 
microliters of octan-l-ol (Sigma, Cat.#0-4500) and freshly prepared sodium boron 
hydride (0.2 mL, 200 mg/mL in 2 M ammonia; Sigma, Cat.#S-9125) were added to 
reduce the hydrolysate. The mixture was kept at 40 °C for 30 min. After that, 0.4 
mL of glacial acetic acid was added and vortex-mixed. An aliquot of the mixture 
(0.2 mL) was transferred to a new test tube. Then, 0.3 mL of 1-methylimidazole 
(Sigma, Cat.#336092) as- catalyst and 2.0 mL of acetic anhydride was added to 
acetylate the mixture. The mixture was vortex-mixed and left at room temperature 
for 10 min. Five milliliters of distilled water was then added, the mixture was 
vortex-mixed and cooled under tap water to room temperature. One milliliter of 
dichloromethane was added and the mixture was vortex-mixed and stood for 10 
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minutes for phase separation. After the upper phase was removed, the lower phase 
was washed twice with 1 mL of water. The lower phase was dried with anhydrous 
sodium sulfate and then stored in a vial at -20 °C before GC analysis. 
2.2.1.1.3 Gas chromatography (GC) 
The alditol acetates derivatives of the neutral sugars were quantified by gas 
chromatograph (Hewlett-Packard 6890，USA) using an Alltech DB-225 capillary 
column (15 m x 0.25 mm i.d.，0.25 i^m film) and oven temperature program of initial 
temperature 170 °C，followed by a temperature rise o f 2 'C/min to 220 °C with a final 
hold of 10 minutes. The injector and detector were at 270 °C. The carrier gas was 
helium and detection was by flame ionization. Individual sugars were corrected for 
losses during hydrolysis and derivatization, and for the response to the flame 
ionization detector. Monosaccharide calibration was made with fucose, rhamnose, 
ribose, arabinose, xylose, mannose, galactose, glucose, glucosamine and 
galactosamine. The N-acetylglucosamine was detected as glucosamine because the 
N-acetyl group at C-2 would be deacetylated by the sulphuric acid hydrolysis (Pazur, 
1994). The values for monosaccharides were expressed as polysaccharide residues 
(anhydro-sugars) by multiplying the amounts of pentoses with a factor of0.88, 
hexoses with a factor of 0.90 and deoxypentoses with a factor of 0.89. 
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The amount ofthe monosaccharides was calculated as below: 
Amount of individual Peak area monosaccharide in sample x Amount of allose (mg) 
monosaccharide (mg) Peak area . s e in sample 
After determining the amount of different monosaccharides, their corresponding 
percentages by weight in the sample were calculated as follows. 
Monosaccharide (Rf x coefficient x dilution factor) x Amount of monosaccharide (mg) x 100% 
% by weight Sample weight (mg) 
Rf-response factor determined from monosaccharide standard 
The relative amount (normalized) of monosaccharide as % of total 
monosaccharide in the sample was calculated as follows. 
% of individual monosaccharide x 100% 
Normalized monosaccharide % 
Total % monosaccharide in the sample 
2.2.1.2 Determination of total sugar by phenol-sulfuric acid method 
The samples, which were hydrolysate obtained previously from acid 
depolymerisation (2.2.1.1.1), were diluted 20 times in 2 M concentrated sulphuric 
acid before the analysis. Then, 0.5 mL of diluted sample solution was vortex-mixed 
with 0.5 mL of 5% phenol in water. After the addition of 2.5 mL of 18 M 
concentrated sulphuric acid rapidly from a glass dispenser, the mixture was 
vortex-mixed, and was allowed to stand for 30 minutes at room temperature. The 
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amount of sugar was measured by reading absorbance at 490 nm (Dubois, 1956). A 
calibration curve was prepared by using a set of glucose standard of concentrations 
100 ^g/mL, 50 ^ig/mL, 25 ^ig/mL, 12.5 ^g/mL, 0 ^ig/mL. The formula of 
calculating the % total sugar was shown below: 
Conc. oftotal sugar from standard curve (^ig/mL) x 4.2mL x 20* 
o/o Total sugar x 100% 
Sample weight (^ig) 
* A 20 times dilution was made in the above procedures 
2.2.1.3 Determination of protein content by Lowry-Folin Method 
Lowry reagent solution (Cat.#L3540, Sigma) and Folin & Ciocalteu's Phenol 
Reagent Working Solution (Cat.#P5656, Sigma) were prepared according to the 
manufactory instructions. The Lowry-Folin method (Lowry et al., 1951) was used 
to determine the protein content in mPRSon and PRW. 
Protein standard solutions with different concentrations: 0 ^g/mL, 25 ^ig/mL, 50 
^igAnL, 100 ^ig/mL and 150 ^ig/mL, were prepared by adding distilled water to 
bovine serum albumin (BSA) to a final volume of 1.0 mL. Sample solution was 
prepared by dissolving about 1 mg (samples weight) into 1.0 mL distilled water and 
diluted 2 times to make with a final concentration of 500 i^gAnL for the protein 
determination. One milliliter of two diluted sample solutions was transferred to 
new test tubes, respectively. 
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One milliliter of Lowry reagent solution was added to all standard solutions and 
sample solutions, and then mixed well. The solutions were then allowed to incubate 
at room temperature for 20 min. After that, 0.5 mL of Folin & Ciocalteu's Phenol 
Reagent Working Solution was added to each tube with rapid and immediate mixing 
to allow color development for 30 min. Solutions were transferred to cuvettes and 
absorbance was measured at 750 nm against blank (distilled water). A standard 
curve was plotted by using absorbance at 750 nm against concentration of BSA. 
The original protein content of each sample was determined correspondingly from 
the curve and by multiplying an appropriate dilution factor. 
Conc. of protein from standard curve (^g/mL) x 1 mL x 2* 
o/o Protein = x 100% 
Sample weight (^g) 
*A 2 times dilution was made in the above procedures 
2.2.1.4 Size exclusion chromatography by high pressure liquid 
chromatography (HPLC) 
Size exclusion column TSK gel G5000 PW (30 cm x 7.5 mm i.d.，Cat.#8-05764, 
Supelco) with PWH Guard column (7.5 cm x 7.5 mm i.d., Cat.#8-06762, Supelco) 
were used for determine the molecular weight profile for PRW and mPRSon. The 
profile given by a range of P-82 pullulan standards at a concentration of 1 % in 
autoclaved ultrapure water were used as a standard. The solvent used was ultrapure 
water. The flow rate was set at 0.7 mL/min. Temperature of the column was 
controlled externally at 3 0 T . Each sample or standard was allowed to run for 30 
min. Signals from each sample or standard were detected by a refractive index (RI) 
detector. 
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2.2.1.5 Endotoxin detection 
Endotoxin was detected by the semi-quantitative E-TOXATE™ [Limulus 
amebocyte lysate (LAL)] test (Cat.# ET0200, Sigma, USA) (Bang, 1956; Levin and 
Bang, 1964; Levin and Bang, 1968). The E-TOXATE Reagent is prepared from a 
lysate ofthe circulating amebocytes of the horseshoe crab, Limulus polyphemus. 
When the lysate is exposed to a small amount of endotoxin, i.e. lipopolysaccarides 
from the walls ofGram-negative bacteria, it increases in opacity as well as viscosity, 
and may form gel, depending on the concentration of endotoxin present in the 
samples. The underlying mechanism for this reaction is not fully understood, it 
appears to be analogous to the clotting of mammalian blood involving two steps -
activation oftrypsin-like preclotting enzymes by endotoxin in the presence of 
calcium ions, following by limited proteolysis and modification o f a "coagulogen" 
by the activated enzymes to produce a clottable protein. This endotoxin-mediated 
effect is tightly related to the biologically active or "pyrogenic" portion ofthe 
molecule, since it has been shown that "detoxified" endotoxin gives a negative 
Limulus lysate test. The kit was used by following the manufacturer's 
recommended procedure. All equipment and ultra-pure water were autoclaved 
before use. In brief, designated volume of sample dilutions (400 ^igAnL, and 100 
^ig/mL)，water, and Endotoxin Standard Dilutions (400 EU/mL, 40 EU/mL, 4 EU/mL, 
0.5 EU/mL, 0.25 EU/mL, 0.125 EU/mL, 0.06 EU/mL, 0.03 EU/mL, 0.015 EU/mL, 
and 0 EU/mL), were added directly to the bottom oflabeled non-siliconized glass 
culture tubes in duplicate. Then, the E-TOXATE Working Solution was added to 
each tube from the lowest to highest positive standard by inserting pipette to just 
above the contents and allowing lysate to flow down the side oftube, thereby 
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avoiding contact and possible cross-contamination. The mouths of tubes were 
covered with Parafilm, the tube contents were mixed gently, and then incubated for 1 
hour at 37°C without disturbance. After 1 hour incubation, the tubes were slowly 
inverted 180° one at a time to observe for evidence of gelation. A positive test is 
the formation of a hard gel that permits complete inversion of the tube without 
disruption of the gel. All other results including soft gels, turbidity, increase in 
viscosity, or clear liquid are considered negative. 
2.2.2 Measurement of Bioactivities 
2.2.2.1 Trypan blue exclusion assay 
After harvest of treated cells, 50 i^L of cell suspension in each well was added to 
50 i^l of 0.4% trypan blue solution (0.4% in PBS), and gently mixed. 10 i^l of stained 
cells was placed in a Hemocytometer. The number of viable (unstained) cells were 
counted. To find out the live cell density, the average number of unstained cells in 
each quadrant was calculated, and it was multiplied by 2 x 10^ cells/ml. 
2.2.2.2 MTT cell proliferation assay 
The MTT assay is colorimetric assay for measuring the activity of 
mitochondrial reductase which indicates the metabolic activity (Mosmann, 1983). 
The active reductases reduce yellow MTT to purple formazan dyes in viable cells. 
Dimethyl sulfoxide (DMSO) was used as a solubilization solution to dissolve the 
insoluble purple formazan product into a colored solution. The absorbance of this 
colored solution can be quantified by measuring at 570nm by a spectrophotometer. 
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THP-1 cells (5 X 10^) in 100 ^L of complete medium were seeded on 
flat-bottomed 96-well plate (Cat. # 83.1835, Sarstedt) in four replicates 24 hours 
before 100 i^L of control and samples to be tested were added. Five concentrations 
ofmPRSon and PRW [25, 50, 100，200, and 400 [ig/mL in complete media], and 
negative control (0 p,g/mL), were incubated with the cells for 24 and 48 hours, 
immature BMDCs (1 x 10^) in 100 i^L of complete medium were seeded on 
flat-bottomed 96-well plate in seven replicates. mPRSon (400S) and PRW (400W) at 
400 ^ig/mL in complete medium, and negative control (0 ^g/mL), were incubated 
with the cells for 48 hours. 
By the end of the treatment, the culture medium was replaced with 100 i^L of 
fresh complete medium. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide, MTT (Cat.#M5655, Sigma), 10|iL at the concentration 50 mg/mL in sterile 
IX PBS, were added to the wells and further incubated (4 h for THP-1; 20 h for 
immature BMDCs). After aspirating MTT-medium solution, the purple formazan 
reaction product was extracted by mixing with 100 i^L DMSO using a multi-channel 
pipette. The absorbance was measured by a microplate reader (SpectraMAX 250, 
Molecular Devices, Sunnyvale, CA) at a wavelength of 570 nm. The samples were 
compared with the negative control to calculate the proliferation ratio % by the 
formula below: 
(absorbance of treatment cells - absorbance of control cells) 
Proliferation ratio (%) = X 100% 
absorbance of control cells 
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2.2.2.3 BrdU cell proliferation assay 
Chemiluminescent cell proiliferation ELISA 5 -bromo-2-deoxyuridine (BrdU) 
incorporation assay (Cat.# 11669915001, Roche Applied Science, East Sussex, UK) 
is a method based on the incorporation of pyrimidine analogue, BrdU which is a 
synthetic nucleoside analogue of thymidine (Gage, 2000). BrdU is phosphorylated 
by cells to BrdUTP which is incorporated into newly synthesised DNA in the 
proliferating cells during S phase instead of deoxythymidine triphosphate (dTTP). 
The procedures were according to those instructions described in the product 
protocols. In brief, THP-1 cells (5 x 10^) in 100 |iL of complete medium were 
seeded on flat-bottomed 96-well plate in four replicates 24 hours before 100 i^L of 
control and samples to be tested were added. Two concentrations of mPRSon and 
PRW [100，and 400 |ig/mL in complete media], and negative control (0 ^ig/mL) were 
incubated with the cells for 24 and 48 hours. By the end of the treatment, 20 i^L of 
BrdU-labeling solution was then added to each well and the plate was further 
incubation for 4 hours to allow the incorporation ofBrdU into DNA synthesizing 
cells. The plate was centrifuged at 1500 rpm for 10 min, the media were thoroughly 
aspirated, and then the plate was dried in oven at 60°C for 30 min and then stored at 
4°C. The cells were fixed with the FixDenat solution, and were then incubated with 
the anti-BrdU-POD working solution (100 i^L / well). The cells were washed 3 
times by washing solution, and then incubated with the substrate component solution 
and shook for 5 min. The relative light unit per second (rlu/s) emitted from the 
reaction mixture was measured by a luminometer (ML3000 microtiter plate 
luminometer, Dynatech Laboratories, Chantilly, VA). The samples were compared 
with the control. The results were expressed as cell proliferation % calculated as: 
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rhVs of treated cells 
Cell proliferation % = X 100% 
rlu/s of control cells 
2.2.2.4 Expression of cell surface markers 
THP-1 cells (2 X 10^ cells/mL) were incubated with 100 and 400 i^gAnL of 
mPRSon and PRW for 48 h, while immature BMDCs (2.5 x 10^  cells/mL) were 
incubated with 400 ^g/mL of mPRSon and PRW for 48 h. After incubation, the 
cells were harvested and collected into 15 mL tubes, then span at 1000 rpm at 4°C 
for 5 min. The supernatant was collected into sterile vials and stored at -20°C for 
cytokine prolife array analysis. The cells were washed twice in 3 mL of cold stain 
buffer (5% FBS and 0.1% sodium azide in IX PBS), and cell count was carried by 
using trypan blue dye exclusion method described in 2.2.2.1. The cells were 
pelletted by centrifugation at 1500 rpm at 4 � C for 5 min. The cell pellets were 
re-suspended with cold stain buffer to a final concentration of5 x 10^ cells /mL. 
Pre-diluted mAbs were delivered to the wells of a round-bottom microtiter plate in a 
volume of 10 i^l. 100 i^l aliquots of the cell suspension (5 x 10^ cells) were then 
distributed to the plates already containing 10 ^L of pre-diluted mAbs (For human: 
anti-CD14, anti-HLA-DR; For mouse: anti-CDllc, anti-CD40, anti-CD80, 
anti-CD86, anti-I-Ad/I-Ed, anti-CD4, anti-CD8a), and incubated for 30 min at 4 � C , 
protected from light. Thereafter, each well was then washed by 200 ^L of cold 
stain buffer twice. The cells were then centrifuged at 1800 rpm for 5 min, and then 
the stain buffer was carefully aspirated. The cells were re-suspended in 300 i^L of 
1.50/0 paraformaldehyde solution, and stored at 4 � C overnight, and then analyzed by 
CXP 500 flow cytometer (Beckman Coulter, Miami, FL). 
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2.2.2.5 Phagocytosis / Endocytosis of FITC-labeled dextrans 
THP-1 (2 X 105 cells/mL) were incubated with 100 and 400 ^ig/mL ofmPRSon 
and PRW for 48 h, while immature BMDCs (2.5 x 10^ cells/mL) were incubated with 
400 ^ig/mL of mPRSon and PRW for 48 h. After incubation, the cells were 
harvested and collected into a 15mL tubes, and cell count was carried by using 
trypan blue dye exclusion method, live cells (3 x 10^) were pelletted, and then 
incubated with 1 mL ofFITC-labeled dextrans (1 mg/mL) in complete media at 4°C 
or 37°C for 1 h. A non-stained control using PBS at 4°C was served as the 
background fluorescence. Thereafter, the cells were then washed by 5 mL of cold 
PBS three times. The cells were then analyzed by CXP 500 flow cytometer 
(Beckman Coulter, Miami, FL). 
2.2.2.6 Nitric oxide production assay 
Nitric oxide ¢^0) production was measured by mean of nitrite (NO!) levels 
using the Griess Reagent System (Cat.# G2930, Promega, USA) (Griess, 1879). 
The kit was used according to the manufactory instructions. In Brief, THP-1 cells 
(5 X 104) in 100^L ofcomplete medium were seeded on round-bottomed 96-well 
plate in four replicates 24 hours before 100 i^L of control and samples to be tested 
were added. Two concentrations of mPRSon and PRW [100，and 400 ^ig/mL in 
complete medium], and negative control (0 ^ig/mL) were incubated with the cells for 
48 h. • 
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Immature BMDCs (1 x 10^) in 100 ^L of complete medium were seeded on 
round-bottomed 96-well plate in four replicates 24 hours before 100 |iL of control 
and samples to be tested were added. mPRSon and PRW (400 ^ig/mL) in complete 
media, and negative control (0 ^ig/mL) were incubated with the cells for 48 h. 
After incubation, the plate was centrifuged at 2000 rpm for 5 min, and 50 i^L of 
culture medium in each well was transferred to a flat-bottomed 96-well plate. 
For accurate quantitative measure of nitrite levels in samples, a nitrite standard 
reference curve was prepared in each assay by serially diluting the provided 0.1 M 
nitrite solution 1:1000 in uncultured complete media to give the final volume of 50 
i^L in each well, and the nitrite concentration of 0 ^M, 1.56 ^iM, 3.13 i^M, 6.25 |iM， 
12.5 _ , 25 ^M, 50 _， 1 0 0 i^M. 
Before measurement, 1% sulfanilamide in 5% phosphoric acid (sulfanilamide 
solution) and 0.1% N-1 -napthylethylenediamine dihydrochloride in water fNED 
solution) to equilibrate to room temperature. Fifty microliters of sulfanilamide 
solution was dispensed to each well using a multichannel pipettor, including samples 
and standard, and then incubated at room temperature for 5 min, protected from light. 
And then 50 |iL ofNED solution was dispensed to all wells using a multichannel 
pipettor, and then incubated at room temperature for 5 min, protected from light. 
The reaction was called Griess diazotization reaction (Figure 2.4), in which 
sulfanilamide is quantitatively converted to a diazonium salt by reaction with nitrite 
in acid solution. The diazonium salt is then coupled to N-1 -naphthylethylenediamine 
0^ED). An azo compound in purple colour was formed immediately and could be 
spectrophotometrically quantitated. The absorbance of this azo compound was 
measured within 30 min in the microplate reader at a wavelength of 530 nm. To 
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generate a nitrite standard reference curve, the average absorbance value of each 
concentration of the nitrite standard was plotted as a function of "Y" with nitrite 
concentration as a function of "X". The concentration of each sample was 
determined by compared its average absorbance value with the nitrite standard 
reference curve. 
NO2" H2O 
H 2 N O 2 S ^ Q ^ N H 2 ^ ^ H 2 N O 2 S ^ Q ^ N , > p ^ H ^ ^ N H , 
Sulfanilamide .,cn ^ ^ ^ 
r o NH 
H 2 N O 2 s - ^ ^ N = N - ^ ^ - N - ' ^ ^ 2 
0 
Azo Compound 
Figure 2.4: Griess diazotization reaction involved in the measurement of nitrite. 
2.2.2.7 Reactive oxygen species production 
THP-1 (2 X 105 cells/mL) were incubated with 0，100 and 400 ^ig/mL of 
mPRSon and PRW for 6 h, 24 h, and 48 h. After incubation, the cells were 
harvested and collected into a 15 mL tubes, and cell count was carried by using 
trypan blue dye exclusion method. Live cells (3 x 10^) were pelletted, and then 
incubated with 1 mL of 2',7'-Dichlorofluorescin diacetate (DCFH-DA; 0.5 jigAnL) 
in IX PBS at 37°C for 10 min. A non-stained control using IX PBS at 4°C was 
served as the background fluorescence. DCFH-DA diffuses into cells and is 
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hydrolyzed into 2',7' -Dichlorofluorescin (DCFH) is a cell permeable reagent for use 
in detection of peroxidase activity inside living cells (Bass et al, 1983). 
Non-fluorescent intracellular DCFH is oxidized into highly fluorescent 
dichlorofluorescin (DCF) by H2O2. Thereafter, the cells were then washed by 5 mL 
of cold PBS three times. Finally, the cell pellets were re-suspended in 400 jiL of 
cold stain buffer at 4°C, and then analyzed by CXP 500 flow cytometer (Beckman 
Coulter, Miami, FL). 
2.2.2.8 Determination of cytokine profile using cytokine antibody array 
The cytokines released to the media from THP-1 cell line and immature 
BMDCs were analyzed for the cytokine profile using RayBio® Human Cytokine 
AntibodyArray 3 (Cat.#AAH-CYT-3-8, RayBiotech), and RayBio® Mouse Cytokine 
Antibody Array 2 (Cat.#AAM-CYT-2-8, RayBiotech) respectively. The two 
antibody array systems detected different kinds of cytokines, which shared the same 
principle and protocols to be mentioned as follows. 
Because of simultaneous multiple detection of cytokines, different cytokine 
antibodies were pre-coated on array membranes. Each membrane was first placed 
into each well of an eight-well tray, 2 mL of IX blocking buffer was added to 
incubate for 30 minutes to block the membrane. After decanting the blocking 
buffer, 1 mL of diluted culture medium (10-fold dilution with IX blocking buffer) 
was added for a further incubation of 1 to 2 hours at room temperature. Mouse 
culture medium was then removed and the membrane was washed 3 times with 5 mL 
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of IX wash buffer I at room temperature with shaking for 5 minutes each. Then the 
membrane was washed twice with 2 mL of IX wash buffer II at room temperature 
with shaking for 5 minutes each. One milliliter of diluted biotin-conjugated 
anti-cytokines antibodies was added to each membrane and was allowed to incubate 
ovemight. Then the membrane was washed again as mentioned before with wash 
buffer I and 11. After that, 2 mL of 1000-fold diluted HRP-conjugated streptavidin 
was added to the membrane and incubated for 2 hours. The membrane was washed 
yet again as mentioned before with wash buffer I and 11. Subsequently, two 
different detection buffers were mixed and 500 ^L of this mixture was added to each 
membrane and incubated for 2 min at room temperature. Excess detection duffer 
mixture was drained off and the membrane was covered with plastic sheet. The 
membrane was then exposed to x-ray film and signals were detected using film 
developer. 
2.2.2.9 Cell cycle analysis 
The effect of PRW on cell cycle was assessed by flow cytometry. THP-1 cells (2 x 
10^ cells/mL) was incubated with 400 ^ig/mL ofPRW for 24 h and 48 h, respectively. 
After the incubation, the wells were washed with cold IX PBS twice and fixed in 
70% cold ethanol and stored at -20°C for 24 h and 48 h. The fixed cells were washed 
with cold PBS twice and re-suspended in 500 i^L of propidium iodide (PI) containing 
RNAase at a concentration of 1 mg/100 mL and kept at 4 °C ovemight. The stained 
cells were analyzed by a CXP500 flow cytometer (Beckman Coulter). Cell-cycle 
phase distribution was analyzed using the Multi-Cycle software (Phoenix Flow 
Systems, San Diego, CA). All tested samples were carried out in duplicates. 
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2.2.2.10 Expression of surface receptors 
THP-1 (2 X 10^  cells/mL) were incubated with 0 ^igAnL, 100 ^ig/mL, and 
400 i^gAnL ofmPRSon and PRW for 6 hours, while immature BMDCs (2.5 x 10^  
cells/mL) were incubated with Op,g/mL and 400 ng/mL of mPRSon and PRW for 6 
hours. After incubation, the cells were harvested and collected into 15 mL tubes, 
then span at 1000 rpm at 4°C for 5 min. The cells were washed twice in 2 mL of 
cold stain buffer (5% FBS and 0.1% sodium azide in IX PBS), and cell count was 
carried by using trypan blue dye exclusion method. The cells were pelletted by 
centrifugation at 1500 rpm at 4°C for 5 min. The cell pellets were re-suspended 
with cold stain buffer to a final concentration of 2 x 10^ cells/mL for THP-1, and 5 x 
10^  cells/mL for BMDCs. Pre-diluted anti-dectin-1, anti-TLR2, and anti-CDl lb 
mAbs were delivered to the wells of a round-bottom microtiter plate in a volume of 
10 i^L. 100 p,L aliquots of the cell suspension (2 x 10^  cells for THP-1, 5 x 10^  cells 
for BMDCs) were then distributed to the plates already containing 10 \iL of 
pre-diluted mAbs, and incubated for 30 min at 4°C, protected from light. Thereafter, 
each well was then washed by 200 pL of cold stain buffer twice. The cells were 
then centrifuged at 2000 rpm for 5 min, and then the stain buffer was carefully 
aspirated. The cell pellets were re-suspended in 400 jiL of cold stain buffer at 4°C, 
and then analyzed by CXP 500 flow cytometer (Beckman Coulter, Miami, FL). 
However, for those with purified mAbs as primary mAbs, the cells pellets were 
re-suspended in 100 |iL of cold stain buffer. Pre-diluted secondary pAb was 
delivered to the wells in a volume of lO ^iL, and incubated for 30 min at 4°C, 
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protected from light. Each well was then washed by 200 ^L of cold stain buffer 
twice. The cells were then centrifUged at 2000 rpm for 5 min, and then the stain 
buffer was carefully aspirated. Finally, the cell pellets were re-suspended in 400 i^L 
of cold stain buffer at 4°C, and then analyzed by CXP 500 flow cytometer (Beckman 
Coulter, Miami, FL). 
2.2.2.11 Statistical analysis 
All analyses were performed in triplicate except otherwise stated. The data were 
recorded as mean 土 standard deviations (SD) of three independent experiments. 
Differences between the mean values of experimental and control groups were 
determined by one-way ANOVA test followed by Student's unpaired Ntest or Tukey's 
multiple comparisons. A confidence level of 5% (p < 0.05) was considered to be 
significant. 
Chapter 3 Results and Discussion 
3.1 Chemical characteristics of sclerotial polysaccharides 
3.1.1. The yield of sclerotial polysaccharides 
Use ofdifferent extraction methods can obtain mushroom polysaccharides with 
different chemical composition as well as biological activities (Lai, 2005; Lai, 2008). 
The structure-activity relationship of mushroom polysaccharide including molecular 
interactions between cell-surface receptors and polysaccharides can be affected by 
parameters including linkages, degree ofbranching, conformation, and molecular 
weight. The inter-conversion of P-D-glucan conformation between triple helix and 
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single helix can be influenced by different chemical and physical extraction methods. 
P-D-glucan would form a random coil conformation at a high temperature (above 
70°C) but change to a single helical conformation when the temperature is lowered to 
room temperature, while some P-D-glucans would adopt a triple helical conformation 
as it is a more stable form after the treatments (Yadomae and Ohno, 1996). 
In order to study the interactions between mushroom polysaccharides with 
different chemical composition from Polyporus rhinocerus (PR) and their 
corresponding receptors, two different extraction methods, hot-water extraction and 
cold alkaline-sonication extraction, were selected to isolate mushroom 
polysaccharides from Polyporus rhinocerus (PR). The yield of the hot 
water-soluble sclerotial polysaccharides (PRW) was 10.3%, while that of the 
cold-alkaline-soluble sclerotial polysaccharides (PRSon) was 84.4% (Table 3.1). 
Table 3.1: The yield of various fractions obtained from Polyporus rhinocerus (PR) by 
different extraction methods 




* The Fraction extracted from micronized sclerotial powder (10-20^m) 
** Micronized PRSon (30-50^m) after extraction from micronized sclerotial powder 
(10-20^im) 
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Hot water is a traditional method to isolate mushroom polysaccharides which 
exerted potent bioactivities (Zhang et al, 2007). The yield of mushroom 
polysaccharides from mushroom sclerotia by hot water extraction is usually low, less 
than 10%. This might be due to the fact that the majority of p-glucans in sclerotia 
was water-insoluble (Marchessault et al., 1977). For example, according to 
previous studies in our laboratory, the total yield of three successive hot 
water-soluble mushroom polysaccharides of unmicronized Pleurotus tuber-regium 
(PTR) sclerotial powder was only 3.6% (Lai, 2005). But the total yield ofthree 
successive hot water-soluble mushroom polysaccharides of micronized Pleurotus 
tuber-regium (PTR) sclerotial powder (60 ^m in particle size) was increased to 
11.6% (Chau, 2008). There is a trend that the yield of hot water-soluble mushroom 
polysaccharides increased with a decrease in the particle size of mushroom sclerotial 
powder (Ghau, 2008). The application of micronisation to sclerotial powder of PR 
(10-20 [im in particle size) before extraction slightly improved the yield of the hot 
water-soluble sclerotial polysaccharides (PRW) which was 10.3% (Table 3.1), when 
comparing with previous studies where the yield ofhot water-soluble mushroom 
polysaccharides of unmicronized PR sclerotial powder was 8.62% (Lai, 2008). 
Besides the yield, it is assumed that PRW should adopt a single helical conformation, 
since the lowering of temperature after hot-water extraction usually resulted in such a 
conformation for P-glucans (Yadomae and Ohno, 1996). 
Sclerotia had a thickened and wood-like textured cell wall structure (Carlite et 
of/.，2001; Hoffman, 1999), so more vigorous extraction methods should be applied to 
obtain a better yield of mushroom polysaccharides. As mentioned above, the 
majority of p-glucans in sclerotia was water-insoluble (Marchessault et al.’ 1977), 
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and the use of diluted alkali as the extraction solvent has been demonstrated to 
greatly increase the yield of water-insoluble P-D-glucans (Mizuno, 1999). 
Therefore, in addition to hot water extraction, cold alkaline-sonication extraction was 
also selected to isolate mushroom polysaccharides. Cold alkaline combined with 
sonication could greatly increase the yield of sonication-associated cold 
alkaline-soluble polysaccharides (PRSon) when compared with hot water extraction 
(Lai, 2005; Lai, 2008). Sonication makes use of ultrasonic energy to break the 
non-convalent bonds between P-glucan-chitin complexes (Chen et al., 1997) in the 
fungal cell wall where cellulose and chitin co-exist as structural components 
(Bartnicki-Garcia, 1970)，and hence facilitates the extraction of mushroom 
polysaccharides. Furthermore, the PR sclerotial powder was micronized before 
extraction to decrease the particle size, which in tum facilities the extraction. This 
explains why the yield ofPRSon from micronized PR sclerotial powder obtained in 
this study (84.4%) (Table 3.1) was higher than that ofPRSon from unmicronized PR 
sclerotial powder (73.1 %) when compared with previous studies (Lai, 2008). Since 
PRSon gradually formed a gel during dialysis, a helical conformation but not a 
random coil conformation should be adopted after the removal ofthe alkaline 
condition and physical sonication treatment (Lai, 2008; Yadomae and Ohno, 1996). 
As cold alkaline extraction would give sparingly water-soluble mushroom 
polysaccharides (Lai, 2005; Lai, 2008), micronization was applied to reduce the 
particle size ofPRSon extracts, so as to decrease the bulk density, and increased its 
water solubility. The micronized PRSon (mPRSon) with particles sizes of 30 i^m to 
50 i^m was micronized PRSon, which could give a clear solution without any 
precipitates in water and culture media, with a loss of only 2.4% during 
micronisation ofPRSon to have the yield 82.0% (Table 3.1). 
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3.1.2 Total carbohydrate content of sclerotial polysaccharides 
The total carbohydrate content was measured by the phenol-sulfuric acid assay 
using glucose as the standard for constructing a calibration curve. Because the use 
ofdifferent extraction methods, the total carbohydrate content found in PRW was 
significantly different from that found in mPRSon, even they came from the same 
mushroom sclerotia PR. PRW had a relatively lower total carbohydrate content 
(35.2%) than that ofmPRSon (97.9% ) (Table 3.2). This indicated that other 
substances were present in a considerable amount in PRW, whereas mPRSon was a 
rather pure carbohydrate. The effect of micronisation on the total carbohydrate 
content in the PR sclerotial polysaccharides was consistent with that of the extraction 
yield, because water-insoluble mushroom polysaccharides are the major structural 
component in fungal cell wall (Marchessault et al., 1977), and micronization could 
reduce the particle size and break down the cell wall materials for facilitating the 
extraction of cell wall polysaccharides (Chau, 2008). Compared with the total 
carbohydrate content in PRW (33.1%) and PRSon (92.1%) extracted from 
unmicronized PR sclerotial powder in previous studies (Lai, 2005; Lai, 2008), the 
total carbohydrate content in both PRW (35.2%) and mPRSon (97.9%) extracted 
from micomized PR sclerotial powder in this study were also slightly higher. 
Table 3.2: The chemical composition of various fractions obtained from Polyporus 
rhinocerus (PR) by different extraction methods 
Fractions % Total Carbohydrate % Protein 
mPRSon 97.9士10.9 1.7土0.1 
PRW 35.2±2.0 53.5士6.8 
Data are means of three independent experiments (±SD). 
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3.1.3 Protein content of sclerotial polysaccharides 
The soluble protein content was detected by the Lowry-Folin method. BSA 
was used as a protein standard to generate a calibration curve. Same as the total 
carbohydrate content, the soluble protein content found in PRW was very much 
higher than that found in mPRSon, probably due to the use of different extraction 
methods. The PRW was found to have a much higher soluble protein content 
(53.5%) and this result was in line with its relatively low carbohydrate content 
(35.2%) (Table 3.2). However, mPRSon had a very low soluble protein content 
(1.7%), and this also matched with its high carbohydrate content (97.9%) (Table 3.2). 
Therefore, protein was found to be the major component in PRW obtained by hot 
water extraction, while carbohydrate was shown to be dominant in mPRSon obtained 
by sonication-associated cold-alkaline extraction. 
3.1.4 Monosaccharide profiles of sclerotial polysaccharides from PR by gas 
chromatography (GC) 
The major monosaccharide component in PRW and mPRSon was glucose. 
mPRSon was almost a pure glucan with 100.0% of glucose, while PRW had a 
relatively lower glucose content (87.76%) (Table 3.3). Previous studies have shown 
that reduction of particle size could improve the purity of glucans (Chau, 2008). A 
decrease in glucose content (98.4%，98.3%, 94.8%, and 81.1%, respectively) in the 
hot water extracts obtained from micronized mushroom sclerotial PTR was observed 
with an increase in the particle sizes ofPTR (10 ^im, 60 ^im, 200 |im，and 500 ^im, 
respectively) (Chau, 2008). This was similar to the present results that the glucose 
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content in PRW (87.8%) and mPRSon (100.0%) obtained from miconised PR 
sclerotial powder (10-20 ^im) was relatively higher than that in PRW (59.7%) and 
PRSon (99.0%) obtained from unmicronised PR sclerotial powder in our previous 
studies (Lai, 2005; Lai, 2008). 
Other than glucose, mannose was the second major monosaccharide component 
present in PRW, which constituted 12.2% (Table 3.3). This indicated that some hot 
water-soluble heterglycans such as mannoglucan might be present in PRW. 
Previous studies have also shown that the average amount of mannose in 
polysaccharides extracted from micronized mushroom sclerotial PTR powder (1.29%, 
1.67%，5.22%, and 13.9%, respectively) increased with the particle size (10 ^tm, 60 
^m, 200 ^im, and 500 |xm, respectively) (Chau, 2008). This was in line with the 
results in this study that the mannose content in PRW (12.2%) from miconised PR 
sclerotial powder (10-20 ^im) was relatively lower than that in PRW (17.1%) from 
unmicronised PR sclerotial powder in our previous studies (Lai, 2005; Lai, 2008). 
No fucose, rhamnose, ribose, arabinose, xylose as well as galactose were found 
in mPRSon and PRW. This was similar to that in polysaccharides obtained from 
micronized mushroom sclerotial PTR powder in which the micronized samples had 
no ribose, xylose as well as galactose (Chau, 2008). Reduction ofparticle size of 
mushroom sclerotial powder might greatly increase the yield ofglucan (hence the 
glucose content) making the amount of ribose, xylose and galactose became 
insignificant. Glucosamine was detected as N-acetylglucosamine derived from the 
structural component chitin in fungal cell wall (Michell and Surfield, 1967). No 
glucosamine was also found in mPRSon and PRW (Table 3.3), implying that there 
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was no linkage between glucose and chitin because of the absence of glucan-chitin 
complex (Bowman and Feree, 2006). 
In summary, mPRSon and PRW had a very different monosaccharide profiles in 
which mPRSon contained a homoglycan (glucan), while PRW consisted of a 
heteroglycan (mannoglucan). 
Table 3.3: Monosaccharide profile of various mushroom sclerotial polysaccharides 
from Polyporus rhinocerus (PR) 
Mushroom sclerotial polysaccharides 
PRW mPRSon 
Fucose n.d. n.d. 
Rhamnose n.d. n.d. 
Ribose n.d. n.d. 
Arabinose n.d. n.d. 
Xylose n.d. n.d. 
Mannose 12.2 n.d. 
Galactose n.d. n.d. 
Glucose 87.8 100.0 
Glucosamine n.d. n.d. 
Galactosamine n.d. n.d. 
n.d.: not detected 
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3.1.5 Molecular weight of sclerotial polysaccharides from PR by size 
exclusion chromatography (SEC) 
HPLC is an analytical technique that separates a mixture based on the different 
compatibility of sample components for the eluant (mobile phase) and stationary 
phase. Size exclusion chromatography (SEC) is a HPLC technique that separates 
different components in a sample mixture based on their sizes. It is widely used for 
separation and characterization of oligosaccharides in a mixture based on their sizes. 
Molecules in an eluant buffer are forced into a closed column filled with a gel 
packing of clearly defined particle pore size. Smaller molecules in the samples 
retained in the column and take longer time to be eluted out than the larger molecules. 
The elution time is inversely correlated to the molecular weight of the sample 
component. The eluent from the column is monitored by using one or more 
detectors； Refractive index detectors are usually used alone, or in combination with 
ultraviolent and light scattering detectors (Brummer and Cui, 2005; Harris, 2003). 
In this study, a TSK-Gel G5000 PW column was used to separate the 
components in the PRW and mPRSon based on their molecular sizes. The column 
is a commercial size exclusion column, made up with hydrophilic polymer matrix. 
It has excellent chemical and mechanical stabilities, which is usually used with 
aqueous solvents, but is also compatible with up to 50% organic solvent. The 
PW-type resin is less hydrophilic than polysaccharide gels and has a small residual 
negative charge with 10 |xm particle size with 1000A pores. The range ofmolecular 
weight for Polyethylene glycols / Polyethylene oxides (PEGS/PEOS) is 4 - 1000 x 
10^ and for dextrans is 50 - 7000 x 10l 
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Eight pullulan standards were used for constructing the calibration curve 
required for determining the molecular weight of the PRW and PRSon extracts. 
This set of standards is a linear polysaccharide pullulan consisting of maltotriose 
ranging from 0.59 x 10^ Da (P5), 1.18 x 10^ Da (P10), 2.28 x 10^ Da (P20), 4.73 x 
104 Da (P50), 11.2 X 10^ Da (P100), 21.2 x 10^ Da (P200), 40.4 x 10^ Da (P400) and 
78.8 X 104 Da (P800) (Figure 3.1 A). 
Ultrapure water was used both as the mobile phase (eluting solvent) and 
dissolving solvent for PRW and mPRSon in this study, since the hot water-soluble 
polysaccharides were more soluble in ultrapure water, and the micronized 
sonication-associated cold alkali-soluble polysaccharide could be easily dissolved 
into ultrapure water. TSK Gel G5000PW column was used because it had a larger 
pore size that would give better resolution in separating peaks of fractions with large 
molecular weights. 
There were three peaks appeared in the SEC profile of the mPRSon extract 
(Figure 3.1 B). The first and second peaks were larger than the largest pullulan 
standard (P800) which implied that their average molecular weights were > 78.8 x 
10^ Da (Table 3.4). The average molecular weight of the third peak was 1.57 x 10^ 
Da. On the other hand, there were two peaks appeared in that of the PRW extract 
(Figure 3.1 C). The first peak was larger than the largest pullulan standard (P800) 
which implied that its average molecular weights were > 78.8 x 10^ Da (Table 3.4). 
The average molecular weight of the second peak was 4.96 x 10^ Da. It is not 
surprising that more than one fraction was found in PRW since it was a crude extract 
isolated by hot water extraction. 
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Mushroom polysaccharides with high molecular weight are generally 
considered to be more potent than those with low molecular weight (Wasser, 2002; 
Mizuno et al., 1996). The mPRSon and PRW extracts were found to have fractions 
with high molecular weight o f > 78.8 x 10^ Da, and hence they were considered to be 
potent immunomodulatory polysaccharides as they were more effective to bind to the 
surface receptor of P-glucan. 
Table 3.4; The molecular weight of various fractions obtained from Polyporus 
rhinocerus (PR) by different extraction methods 
Molecular weight (Da) 
istpeak 2"dpeak 3^' peak 
mPRSon 
> 78.8 X 104 (29.43%)* > 78.8 x 10' (44.25%) 1.57 x 10^ (26.32%) 
(3 peaks) 
PRW 
> 78.8 X 104 (88.23%) 4.96 x 10^  (11.77%) -
(2 peaks) 
* Figures in parenthesis represent the estimated % proportion ofeach peak based on 
peak areas in the SEC diagram (Figure 3.1). 
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Figure 3.1 : SEC profiles of (A) pullulan standards, (B) mPRSon, and (C) PRW by 
TSK G5000 column. The solvent used was ultrapure water; the flow rate at 0.7 
mL/min; detected by refractive index (RI). 
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3.1.6 Endotoxin test 
Apart from the chemical composition, endotoxin contamination is an important 
issue influencing the safety and potential biological activity of p-glucan (Chan et al., 
2009). Lipopolysaccharide (LPS) is an endotoxin found in the cell wall of 
Gram-negative bacteria, which is one of the most potent immune stimulator. LPS 
consists ofthree major parts including lipid A, core, and polysaccharide chain, and 
among them, lipid A in LPS was found to be the main constituent that can initiate 
immune responses (Dixon and Darveau, 2005). Contamination of LPS can occur 
during the culture of mushrooms or preparation of mushroom polysaccharides (Chan 
et al.，2009), which can lead to false positive results in immune responses triggered 
by the extracted mushroom polysaccharides. Therefore, an endotoxin test is 
necessary to confirm whether the extracted mushroom polysaccharides have been 
contaminated by LPS or not. The Limulus amebocyte lysate (LAL) test was used to 
detect the level of endotoxin in the PR extracts in this study. As mentioned in the 
product instructions, a positive test is the formation of a hard gel after incubation that 
permits complete inversion of the tube without disruption of the gel. And all other 
results including soft gels, turbidity, increase in viscosity, or clear liquid are 
considered negative. The endotoxin standard dilutions were used as positive 
standards to identify which concentration of endotoxin would give a hard gel and 
have a harmful effect causing the circulating amebocytes of the horseshoe crab 
become clotted. The endotoxin standard dilution 0.25 EU/mL, 0.5 EU/mL, 4 
EU/mL，40 EU/mL, and 400 EU/mL gave hard gels, indicating that these 
concentrations of endotoxin are harmful enough to cause the clotting of lysate. A 
concentration of 400 ^ig/mL and 100 ^ig/mL ofmPRSon and PRW gave soft gels, 
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indicating that the endotoxin levels in these samples should be lower than 0.25 
EU/mL which act as the concentration of positive reference, which were too low to 
cause the clotting of lysate. 
3.2 Immune responses for human monocytic cell line THP-1 
3.2.1 MTT cell viability assay 
THP-1 is an acute myeloid leukemia (AML) cell line, which had dual 
functions in being leukemic cells for antitumor study and acting as a source of 
monocyte for studying immune responses and immune cell differentiation (Berges et 
ai； 2005; Chan et al., 2008; Ding et al., 2007; Hsu et al, 2009; Lai, 2008). This 
study would focus on the immunomodulatory responses ofTHP-1 cells. 
MTT cell viability assay was used to investigate the general effect triggered 
by the two PR extracts on human monocytic leukemia cell line THP-1. By 
comparing with the negative control, the two PR extracts obtained by different 
extraction methods had different biological effects on THP-1. There was no 
dose-dependent relationship between different concentrations ofmPRSon and THP-1. 
mPRSon could stimulate the growth ofTHP-1 cells significantly after 24 and 48 
hours incubation. The increase in poliferation ofTHP-1 treated with 100 ^g/mL 
(lOOS) and 400 |ig/mL (400S) ofmPRSon were 6.60% {p < 0.01) and 4.54% Q? < 
0.05) after 24 hours of incubation, respectively and 36.25% Qy < 0.005) and 38.26% 
(P < 0.0005) for 48 hours of incubation, respectively (Figure 3.2). These results 
were different from previous studies in which 100 |ig/mL ofunmicronised 
sonication-associated cold alkali-soluble polysaccharide isolated from unmicronised 
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PR sclerotial powder had only 2.66% of inhibition effect on THP-1, though other 
concentrations (25 ^ig/mL, 50 jig/mL, 200 ^g/mL, and 400 ^ig/mL) ofthis 
polysaccharide had the same proliferation effects as mPRSon on THP-1 (Lai, 2008). 
PRW inhibited the growth ofTHP-1 cells significantly in a dose-dependent 
manner after 48 hours of incubation with inhibitory effects on THP-1 of29.06% {p < 
0.01) and 39.38% Q? < 0.005) for 100 ^ig/mL (lOOW) and 400 ^g/mL (400W) of 
PRW, respectively. These results were also different from previous studies in which 
25 ^ig/mL, 50 ^ig/mL, and 100 ^ig/mL ofhot water-soluble polysaccharide isolated 
from unmicronised PR sclerotial powder had proliferative effect on THP-1, while at 
200 ^ig/mL and 400 ^g/mL had the same inhibitory effects as PRW isolated from 
micronised PR sclerotial powder at the same concentrations in this study on THP-1 
was observed (Lai, 2008). 
3.2.2 BrdU cell proliferation assay 
To further confirm the proliferation effects of mPRSon and inhibition effects 
ofPRW on THP-1 treated with 100 ^ig/mL and 400 ^g/mL ofmPRSon (100S and 
400S) and PRW (100W and 400W) as shown by MTT assay, BrdU cell proliferation 
assay which is a method specifically based on the incorporation ofpyrimidine 
analogue，BrdU, into the DNA of proliferating cells during S phase in the cell cycle 
was carried out. 
The results ofBrdU cell proliferation assay were similar to that o fMTT cell 
viability assay in that mPRSon had proliferative effects on THP-1, while the PRW 
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inhibited the cells after 24 and 48 hours of incubation (Figure 3.3). However, a 
significant increase in the percentage ofTHP-1 cell proliferation in a dose-dependent 
manner was observed when the THP-1 cells were incubated with 100S and 400S, 
with 33.59% {p = 0.0527) and 27.71% {p < 0.005) ofproliferation after 24 hours of 
incubation, respectively, but the proliferative effects oflOOS and 400S were 
decreased after 48 hours of incubation to 15.43% {p < 0.001) and 51.40% {p < 
0.0001), respectively (Figure 3.3). 
The inhibitory activity ofPRW extract at 100W and 400W were almost the 
same, which were 54.77% {p < 0.05) and 54.51% {p = 0.0914) respectively, after 24 
hours of incubation, and were 35.41% (p < 0.0005) and 43.67% Q) < 0.005) 
respectively, after 48 hours of incubation. These observations were similar to the 
MTT results of PRW in section 3.2.1. 
MTT cell viability assay together with BrdU cell proliferation assay showed 
that mushroom polysaccharides isolated from PR by hot-water extraction (PRW) and 
micronisation-associated cold-alkaline-sonication extraction (mPRSon) had certain 
biological effects on THP-1, but in order to study their immunomodulatory effects, 
other parameters including morphological change, phenotypic change, and cell 
functions needed further investigation as shown below. 
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Figure 3.2: The dose-dependent curves for the effect triggered by Polyporus 
rhinocerus extracts, mPRSon and PRW, or medium alone as a negative control 
(CTRL), on THP-1 cells after (A) 24 hours and (B) 48 hours incubation determined 
by MTT cell viability assay. Data are means of three independent experiments 
(±SD). Student's /-test was used to compare the treatment groups with the control 
group, and significant differences are d e n o t e d :冊〜< 0.0001，***p< 0.0005，**p< 
0 . 0 0 5 / p < 0 . 0 1 , V < 0 . 0 5 . 
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Figure 3.3: The cell proliferation or inhibition effect triggered by Polyporus 
rhinocerus extracts, 100 ^ig/mL (lOOS) and 400^ig/mL (400S) ofmPRSon and 100 
^g/mL (lOOW) and 400^g/mL (400W) ofPRW, or medium alone as a negative 
control (CTRL) on THP-1 cells after 24 hours and 48 hours incubation determined 
by BrdU cell proliferation assay. Data are means of three independent experiments 
(±SD). Student's ^-test was used to compare the treatment groups with the control 
group, and significant differences are deno ted :漏 p < 0.0001, *** p < 0.0005, ** p < 
0 . 0 0 5 / j 9 < 0 . 0 1 , V < 0 . 0 5 
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3.2.3 Change in cell morphology ofTHP-1 
Cell morphology and cell adhesion were examined under a phase contrast 
microscope. Monocytic THP-1 cells remained in suspension and were spherical in 
shape under normal culture condition of negative control (Figure 3.4 A and D). 
However, after the THP-1 cells were treated with 400W for 24 and 48 hours, the cells 
had obvious change in cell morphology. The cells enlarged with macrophage-like 
cell patterns with pseudopodia and became adherent (Figure 3.4 C and F). The 
number ofcells with morphologic and adherent changes was increased after 48 hours 
of incubation (Figure 3.4 F). Moreover, there was a slightly change in cell 
morphology after THP-1 cells were treated with 400S for 24 and 48 hours (Figure 
3.4 B and E). The cells became less spherical in shape but remained in suspension 
after 24 hours of incubation. The number of cells with morphological changes was 
increased after 48 hours of incubation. 
Cell adhesion is a characteristic of monocyte-to-macrophage differentiation 
(Kindt et al, 2009; Hsu et al., 2009). These changes in morphology and adhesion 
property triggered by the PRW and mPRSon extracts indicated that 400W might have 
the potential to induce fully differentiation from monocytes to macrophages, while 
400S might have only stimulation without cell terminal differentiation. Similar 
changes had also been observed in other mushrooms. Previous studies have shown 
that the polysaccharide-rich extracts from Ganoderma lucidum could induce cell 
morphological changes, adhesion property and cell terminal differentiation in THP-1 
(Chan et al., 2007; Hsu et al., 2004 and 2009). 
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Figure 3.4: The effect ofmorphological changes triggered by Polyporus rhinocerus 
extracts, medium alone as a negative control (CTRL) after (A) 24 hours and (B) 48 
hours, 400^ig/mL of mPRSon (400S) after (C) 24 hours and (D) 48 hours, and 
400^ig/mL ofPRW (400W) after (E) 24 hours and (F) 48 hours on THP-1 cells are 
shown by under phase-contrast microscope. 
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3.2.4 Phenotypic maturation of THP-1 
Increased expressions of CD14 and MHC class II molecules could be 
regarded as differentiation markers of monocytes to macrophage in previous studies 
(Ding et al, 2007; Hsu et al, 2009; Kindt et al., 2007). CD14 is a 
glycosylphosphatidylinositol (GPI)-linked protein containing leucine-rich repeats, 
which binds to LPS-binding protein (LBP), and delivers the complex ofLPS-LBP to 
TLR4 receptor, leading to immune responses (Miyake, 2007). The expression of 
MHC class II molecules is essential to present antigens and activate T cells, which 
collaborate between the innate and adaptive immune systems (Kindt et al., 2007). 
To further investigate the effects of mPRSon and PRW on leukemia cell 
differentiation, the surface expression of specific macrophage differentiation markers 
CD14 and antigen-presenting MHC class II molecule HLA-DR related to 
macrophage differentiation were detected by flow cytometry. 
The effects of mPRSon and PRW on surface markers in THP-1 cells were 
different after treatment for 48 hours (Figure 3.5). By comparing with the 
non-treated cells in negative control, both of 100W and 400W significantly 
increased the expression of surface marker CD14 on THP-1 cells, from 16.44 % to 
31.82% {p < 0.05), and 51.77% {p < 0.0005), respectively. Furthermore, both 
100W and 400W had also significant increase in the expression of antigen-presenting 
marker HLR-DA from 27.67 % to 42.50% {p < 0.01) and to 38.54% {p < 0.05)， 
respectively (Figure 3.5). The cells treated with 100S and 400S showed slightly 
increase in CD14 and HLA-DR, but no significant difference {p > 0.05) between 
untreated cells in negative control was found. 
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Previous studies had showed that the differentiated THP-1 cells directly 
triggered by the extracts from medicinal mushroom G lucidum also had increase in 
surface maiker CD 14 (Hsu et al, 2009). Furthermore, another mushroom, Fu-Ling 
{Poria cocos) showed activation ofhuman blood mononuclear cells of which 
cultured medium in tum had significant differentiating effects with increase in 
surface marker CD14 on human acute promyelocytic leukemia cell line，HL-60, and 
histiocytic lymphoma cell line, U397 (Chen et ai, 2004)，both of which also 
exhibited monocytic characteristics. These results indicated that 100W- and 400W-
treated cells might differentiate into macrophages with antigen presenting ability, 
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Figure 3.5: Flow cytometric analysis of surface markers (A) CD14, and (B) HLR-DA 
expression on THP-1 upon treatment with Polyporus rhinocerus extracts, 100 ^g/mL 
(lOOS) and 400^ig/mL (400S) ofmPRSon and 100 ^ig/mL (lOOW) and 400^ig/mL 
(400W) of PRW after 48 hours. The results were collected as the percentage of 
positive cells subtracted by that of isotype control antibody-stained cells. Data 
are means of three independent experiments (±SD). Student's Mest was used to 
compare the treatment groups with the control group, and significant differences are 
denoted: # p < 0.01, * p < 0 .05,…p < 0.0005. 
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3.2.5 Up-regulated phagocytic ability ofTHP-1 
Apart from the phenotypic maturation, the functional maturation can be 
assessed by an increase in phagocytic activity after monocytes have differentiated to 
macrophages (Kindt et al, 2007). The phagocytic activity of THP-1 cells was 
examined by flow cytometry using fluorescent FITC-labeled dextrans (FITC-DX) as 
antigens to be up-taken by THP-1 cells at 37°C, and the values are shown as mean 
fluorescence intensity. Parallel experiments at 4°C were performed to show that there 
was no unspecific binding of FITC-DX since phagocytosis was inhibited at low 
temperature (Chan et al, 2008). 
By comparing with the negative control, the degree of up-regulation of 
phagocytosis triggered by 100 ^ig/mL (lOOW) and 400^g/mL (400W) ofPRW in 
THP-1 cells were nearly the same (Figure 3.6). Both 100W and 400W could 
significantly increase the uptake ofFITC-DX, which were from 8.42 to 12.94 {p < 
0.05) and to 12.54 {p < 0.05), respectively (Figure 3.6). However, the mPRSon 
extract at 100 |ig/mL and 400^ig/mL only showed slightly increase on the uptake of 
FITC-DX which were not significant when comparing with the negative control 
(Figure 3.6). This might imply that the PRW extract stimulated monocytic THP-1 
cells to function as macrophages in term of phagocytosis, but the mPRSon extract 
had no such stimulation. Previous studies showed that medicinal mushroom G. 
lucidum could also up-regulate the phagocytosis ofTHP-1 cells when they had been 
stimulated to terminal cell differentiation (Hsu et al., 2009). 
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Figure 3.6: Phagocytic ability ofTHP-1 cells treated with Polyporus rhinocerus 
extracts, 100 ^g/mL (lOOS) and 400^ig/mL (400S) ofmPRSon and 100 ^g/mL 
(lOOW) and 400^ig/mL (400W) ofPRW, or medium alone as a negative control 
(CTRL) after 48 hours. Treated THP-1 cells were incubated with fluorescein 
isothiocyanate-labeled dextrans (FITC-DX) for 1 hour at 37°C (white bar), and then 
washed three times. Parallel experiments were performed for all samples at 4°C 
(black bar). The cells incubated with phosphate-buffered saline (PBS) were worked 
as negative control to serve as background fluorescence. After normalized with the 
background fluorescence, the final values (Grey bars) are determined by the values 
obtained at 4°C subtracted from the values obtained at 37°C which in turn to obtain 
grey bars. Data are means of three independent experiments (±SD). Student's 
"test was used to compare treatment groups with CTRL group, and significant 
difference was denoted by *p < 0.05. 
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3.2.6 Increased nitrite production in THP-1 
The other function indicating cell differentiation of monocytes to 
macrophages is the production of reactive nitrogen species (RNS) (Kindt et al, 
2007). The free radical nitric oxide ¢^0) has a very short half life (1½= 4 seconds), 
which is spontaneously oxidized or reacts with several different molecules under 
physiological conditions, and is hence normally present as its metabolite, nitrite 
(Green et al., 1982). In this study, the Griess Reagent System was used to 
indirectly determine NO level by mean of nitrite. 
Among the two samples, mPRSon stimulated a higher production rate of 
nitrite when compared with PRW at the same concentration (Figure 3.7). THP-1 
treated with 400S and 100S produced 1.26 |xM {p < 0.0001) and 0.92 i^M (p < 0.05) 
nitrite, respectively, which were 189.50% and 112.14% significantly higher than that 
of control (0.43 _ after 24 h incubation. After 48 h incubation, 400S-treated 
THP-1 cells produced 2.34 ^M nitrite (p < 0.005), which was 133.88 % significantly 
higher than that of control (1.00 _ • The production ofnitrite triggered by PRW 
was not significant figures when compared with the responses of untreated cells. 
Interestingly, the production of nitrite triggered by 100W was 0.02 i^M after 
incubation for 24 hours (Figure 3.7). Although the PRW-treated cells were 
stimulated to produce a larger amount of nitrite, the total number ofcells in each well 
was significantly decreased due to the cell death (3.2.1 and 3.2.2). These two 
factors might compensate to give such a result. 
All the results in section 3.2.1 to 3.2.6 indicate that mPRSon and PRW could 
initiate and promote different macrophage functions in monocytic THP-1 cells. 
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PRW could stimulate the cells to have macrophage-like morphology, phenotypic 
maturation, and increase in phagocytic ability, indicating that PRW might trigger cell 
terminal differentiation in THP-1 cells. mPRSon could significantly increase the 
release ofnitrite which is important for humans to fight against fungal and bacterial 
infection. However, this function would be strongly suppressed in patients with 
immunodeficiency diseases such as chronic granulomatous disease because of a 
defect in the ability of phagosome oxidase (phox) to generate the oxidizing species 
(Kindt et al, 2007). Therefore, with the stimulatory effect on nitrite releasing, it 
may suggest that mPRSon have the potential to act as a treatment to these patients for 
fighting against fungal and bacterial infection. 
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Figure 3.7: Nitrite production upon treatment of Polyporus rhinocerus extracts, 100 
^g/mL (lOOS) and 400^ig/mL (400S) ofmPRSon, and 100 |ig/mL (lOOW) and 
400^ig/mL (400W) ofPRW, or medium alone as a negative control (CTRL), for 24 
and 48 hours. Data are means of three independent experiments (±SD). Student's 
^test was used to compare treatment groups with CTRL group, and significant 
differences were denoted by _#p< 0.0001, **p< 0.005, *p< 0.05. 
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3.2.7 Production of reactive oxygen species 
Another oxidant species used by macrophages is the production of reactive 
oxygen species (ROS) after monocytes have been stimulated and differentiated 
(Kindt et al.，2007). Since many reducing agents are present in extracellular fluid, 
the production of ROS including hydrogen peroxide and hypochlorite were measured 
intracellularly by flow cytometry, and the data were presented as mean fluorescence 
intensity (Tarpley et al, 2004). 
Surprisingly, the results ofROS production (Figure 3.8) were contradictory to 
that of nitrite production (Figure 3.7 in section 3.2.6) after treatment ofPRW and 
mPRSon after 24 and 48 hours. On the other hands, PRW at different 
concentrations had a significant inhibition in the ROS production. Compared with 
the negative control, both 100W and 400W remarkably inhibited the production of 
ROS, from 84.30 to only 22.20 and 28.35, respectively after treatment for 24 hours. 
Such inhibition was even stronger after treatment for 48 hours, during which the 
production ofROS for 100W and 400W was suppressed from 208.00 to just 56.10 
and 77.40, respectively. Although mPRSon (100S and 400S) also inhibited the 
production ofROS, there was no significant difference {p > 0.05) when compared 
with negative control (Figure 3.8). 
Actually, the production ofROS triggered by another medicinal mushroom 
Lingzhi (G lucidum) was controversial. One of the studies showed that the 
differentiation triggered by G. lucidum polysaccharides in THP-1 cells increased the 
production of ROS (Hsu et al，2009). However, another study demonstrated that 
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extract ofLingzhi polysaccharides (EORP) decreased the production ofROS in 
human primary monocyte-derived macrophages when compared with LPS, a 
common contaminant with potent immunostimulating functions in mushrooms, 
which increased the production of nitrite, but the EORP extract did not stimulate the 
production of ROS and inhibited that production triggered by LPS. More 
importantly, the EORP extract still stimulated immunomodulating ability such as 
release of IL-1 in the treated primary cells. These suggested that the EORP extract 
were free of LPS contamination (Hsu et al., 2004). Furthermore, previous studies 
also showed that removal ofhydrogen peroxide by all-trans retinoic acid (ATRA) 
synergized with catalase could stimulate macrophage differentiation in THP-1 (Ding 
et al., 2007). 
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Figure 3.8: Reactive Oxygen Species (ROS) production upon treatment ofPolyporus 
rhinocerus extracts, 100 ^ig/mL (lOOS) and 400^ig/mL (400S) ofmPRSon, and 100 
^g/mL (lOOW) and 400^g/mL (400W) ofPRW, or medium alone as a negative 
control (CTRL), for 24 and 48 hours. Data are means of three independent 
experiments (±SD) after normalized with the background fluorescence. Student's 
^test was used to compare treatment groups with CTRL group, and significant 
differences were denoted by ^p< 0.001, **p< 0.005, *p< 0.05. 
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3.2.8 Human cytokines profile array 
The production of cytokines is the hallmark for activation of monocytes. The 
medium which contained the cytokines released by mPRSon- and PRW- treated cells 
and negative control cells after treatment of 24 and 48 hours were analyzed by the 
human cytokine array (Figure 3.9). According to the map ofhuman cytokine array 
(appendix), both PRW and mPRSon could trigger the release of two cytokines: 
interleukin 8 (IL-8) and regulated upon activation, normal T-cell expression and 
secretion (RANTES), after treatment of 24 hours, by compared with the negative 
control (Figure 3.9 B and C). These two cytokines were accumulated in the 
medium to show stronger signals at 48 hours, and the expression triggered by PRW 
were much stronger than that by mPRSon (Figure 3.9 E and F). 
In addition to IL-8 and RANTES, PRW-treated THP-1 cells could also 
express high levels of growth-regulated oncogene (GRO), monocyte chemoattractant 
protein 1 (MCP-1), monocyte chemotactic protein 2 (MCP-2), and interleukin 6 
(IL-6) (Figure 3.9). Among these cytokines triggered by PRW, IL-8, MCP-1, and 
RANTES were the most predominant, with IL-6, MCP-1, and GRO being expressed 
at relatively lower levels (Figure 3.9 C and F). 
Both IL-8 and GRO are belonged to the CXC chemokine subfamily 2 in 
which most of the chemokines are responsible to selectively recruit and activate 
neutrophils, and it is common to find these two chemokines presented together 
(Baggiolini et al, 1994; Kindt et al, 2007). IL-8 might be the most potent CXC 
chemokine for neutrophil chemotaxis which is a mechanism for the recruitment of 
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immune cell to the target site (Van Damme, 1994; Kindt et al.，2007). IL-8 could 
trigger the secretion of superoxide anions and lysosomal enzymes in neutrophils, and 
hence indirectly increased the permeability ofblood vessels for more neutrophil cells 
recruitment (Van Damme, 1994). 
RANTES, MCP-1 and MCP-2 belong to the CC chemokine family which 
I 
serves as the chemo-attactants for the influx of different cells, including monocytes, 
NK cells, T lymphocytes, and basophils, and also functions in activation and 
maturation of mononuclear cells (Baggiolini et al., 1998; Kindt et al., 2007). 
IL-6 is both pro-inflammatory and anti-inflammatory, mainly released by 
macrophages, activated T cells, and endothelial cells. It has multi-functions 
including regulation of acute phase reactions, influencing adaptive immunity through 
proliferation and antibody secretion o f B cells. It is also a hematopoietic cytokine 
which functions as progenitor-cell stimulation (Kindt et aL, 2007). 
In summary, the pattem of cytokines released by mPRSon- and PRW- treated 
THP-1 cells seemed to suggest that the two mushroom extracts can promote the 
recruitment and activation of more neutrophils and monocytes, PRW could also 
activated NK cells, T and B lymphocytes. 
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Figure 3.9: Human Cytokines release upon treatment of Polyporus rhinocerus 
extracts on THP-1, 400^g/mL (400S) ofmPRSon, and 400^ig/mL (400W) ofPRW, or 
medium alone as a negative control (CTRL), for 24 and 48 hours, measured by 
cytokines profile array. Coloured squares indicate different human cytokines. The 
positive results were shown as dark dots, and the higher intensity represented as the 
higher concentration of cytokines released from the cells. Each type of cytokines 
was determined in duplicate shown as a pair of vertical dots in the array. 
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3.2.9 Cell cycle analysis 
Monocytic THP-1 cell line might also provide a prospect for a potential 
leukemic differentiation therapy (Hsu et al., 2004; Hsu et al, 2009). Specific gene 
mutations, including lineage-specific genes and transcription factors involved in 
normal hematopoietic differentiation lead to the pathogenesis of leukemia, which 
block the maturation and cell differentiation process in leukemia (Lowenberg et al., 
1999; Tenen, 2003). Induction of terminal differentiation may be an alternative 
approach to treat leukemia, which cause limited replicate ability and finally undergo 
apoptosis of the leukemic cells. 
As shown in earlier (3.2.1 and 3.2.2)，PRW could inhibit the growth of 
monocytic THP-1 cells in both MTT and BrdU cell proliferation assays, and 
stimulated macrophage-like morphologic change (3.2.3). Moreover, PRW could 
increase the phenotypic maturation, as well as the cell functions for macrophages 
including phagocytic ability and production of nitrite. These results might indicate 
that PRW could stimulate terminal cell differentiation in THP-1 cells. Previous 
studies have shown that the polysaccharide-rich extracts from G lucidum could 
stimulate THP-1 to have cell differentiation which in tum triggered its cell death by 
showing an increase in sub-Gl phase for cell cycle analysis (Cheng et al., 2007; Hsu 
et al, 2004; Wang et al.，1997). Furthermore, another mushroom, polysaccharides 
from Fu-Ling {Poria cocos) showed significant anti-proliferative and differentiating 
effects on monocytic HL-60 and U397 (Chen et aL, 2004). 
Therefore, the effect ofPRW on cell cycle progression in THP-1 cells was 
further analyzed by flow analysis using PI staining. Since 400p.g/mL of PRW was 
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shown to be more effective on stimulation in THP-1 (3.2.1 and 3.2.2), this 
concentration was selected for cell cycle analysis. With the treatment of 400W, the 
percentage of cell population at sub-Gl phase increased after incubation for 24 and 
48 hours (Table 3.5)，suggesting that PRW might trigger terminal cell differentiation 
from monocytes to macrophages in THP-1 cells though onset of apoptosis on THP-1. 
It implied that PRW may also trigger cell differentiation in other leukemic cells, 
which needed further investigation. 
Table 3.5: Flow cytometric analysis on cell cycle by PI staining after THP-1 cells 
were treated with Polyporus rhinocerus extracts, 400^ig/mL ofPRW (400W), or 
medium alone as a negative control (CTRL) after incubation for 24 and 48 hours. 
Different phases in cell cycle (cell %) 
Time samples 
Sub-Gl G0/G1 S G2/M 
CTRL 2.61士0.31 44.50士 1.05 41.52士1.01 13.98士0.63 
24 h 
400W 14.52=h5.31* 51.04士5.73 35.58士4.21 13.44士2.54 
CTRL 2.09士0.40 44.95士0.74 39.63士 1.38 15.42士0.65 
48 h 
400W 10.85±2.89* 42.90土 3.18 37.63 士4.16 19.48士7.73 
Data are means of three independent experiments (±SD). Student's Mest was used 
to compare 400W group with CTRL group, and significant difference was denoted 
by *p<0.05. • 
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3.2.10 Surface receptors expression 
The binding effects between mPRSon and PRW sclerotial polysaccharides and 
the two most widely glucan receptors dectin-1 and CR3 and the well-known pattem 
recognition receptor TLR2 were elucidated on monocytic THP-1 cell line by flow 
cytometry. The cells were pre-treated with mPRSon and PRW at 100 ^ig/mL and 
400p,g/mL for 6 hours and the blocking ofbinding of fluorescence-labeled 
monoclonal antibody (mAb) to the particular receptor was compared. 
The binding of dectin-1 mAb was shown to be significantly blocked in the 
cells pre-treated with mPRSon 0^<O.O5), while that expression was slightly blocked 
in the cells pre-treated with PRW (Figure 3.10). On the other hand, the binding of 
CR3 mAb was significantly blocked by PRW at the concentration of 400 ^ig/mL 
Of^<0.05), while the binding of CR3 mAb was not affected by the pretreatment of 
mPRSon, comparing with the untreated cells (Figure 3.20B). Furthermore, the 
effect of 400S and 400W was significantly different on the binding ofCR3 mAb 
0?<0.05), since the pretreatment ofPRW blocked the binding of mAb, while the 
pretreatment of mPRSon did not block the binding but also increased the expression 
of CR3. However, the binding of TLR2 mAb was not affected by both PRW and 
mPRSon (Figure 3.20C). 
The differences in receptors binding might be related to the structure of the 
sclerotial polysaccharides. Because of the nearly pure glucan (97.86%) in mPRSon, 
the blocking of dectin-1 mAb binding after the pretreatment of mPRSon matched 
with the characteristic of dectin-1 which is responsible for recognizing P-glucan 
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particle zymosan derived from yeast in monocytes/macrophages (Brown and Gordon, 
2001). 
However, the binding of CR3 mAb was significantly blocked in PRW-treated 
cells, which might be due to the large amount of protein content (63.54%) with 
relatively low amount of glucan and mannose (35.20%). This was in agreement 
with the properties of the CR3 receptor that it recognizes polysaccharides containing 
mannose in addition to glucose (Thomton et al., 1996). Previous studies showed 
that CR3 could only promote phagocytosis but not the release ofROS in THP-1 cells 
(Wright and Sliverstein, 1983), which might the possible reason why the production 
ofROS was greatly inhibited in PRW-treated cells. Furthermore, the different 
chemical compositions ofPRW and mPRSon might lead to the significant difference 
in the effect of400S and 400W on the blocking ofCR3 mAb. 
Since CR3 (CDllb) is also the part of cell surface maturation marker for 
macrophage Mac-1 (CDllb/CD18), of which expression increased after monocytic 
THP-1 cells had differentiated to macrophages, triggered by the extracts from G 
lucidum (Hsu et al., 2009), the expression of CR3 was examined by flow cytometry 
after 48 hours to confirm the effect of mPRSon and PRW on the maturation of 
monocytic THP-1 cells (Figure 3.21). Both mPRSon and PRW, especially 100W 
could upregulate the surface expressions of CR3. Taken with the data in section 
3.2.4, it seems that PRW could stimulate monocytic THP-1 cells to differentiate to 
macrophages. 
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Figure 3.10: (A) Dectin-1 / P-glucan receptor; (B) CDllb / Mac-1; (C) TLR2 
expressions upon treatment of Polyporus rhinocerus extracts on THP-1 cells, 
lOO^g/mL (lOOS), 400 ^ig/mL (400S) ofmPRSon, and 100 i^gAnL (lOOW), 400 
^ig/mL (400W) ofPRW, or medium alone as a negative control (CTRL) for 6 hours. 
Data are means of three independent experiments (±SD). Tukey's multiple 
comparison test was used, and different letters indicate significant different at a 
confidence level of5% 0^<0.05). 
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Figure 3.11: CDl lb / Mac-1 expression after treatment of Polyporus rhinocerus 
extracts on THP-1 cells, lOO^ig/mL (lOOS), 400 i^gAnL (400S) ofmPRSon, and 100 
^ig/mL (lOOW), 400 ^ig/mL (400W) ofPRW, or medium alone as a negative control 
(CTRL) for 48 hours. Data are means of three independent experiments (±SD). 
Student's Mest was used to compare treatment groups with CTRL group, and 
significant differences were denoted by * p < 0.05 ** p < 0.005. 
3.2.11 Summary 
Based on the chemical properties of the two mushroom polysaccharides (section 
3.1)，the hot water-soluble sclerotial polysaccharide, PRW contained polysaccharide 
and protein, while the micronized sonication-associated cold alkali-soluble sclerotial 
polysaccharide, mPRSon should be almost a homoglucan. 
To study the immunomodulatory functions ofPRW and mPRSon on the 
antigen-presenting cells (APCs), THP-1 cell line, a well-known cell line model of 
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monocytes, was selected for in vitro immunomodulatory studies, since 
monocyte/macrophage is one of the major APCs. PRW showed inhibitory effects 
while mPRSon showed proliferative effects on this cell line (sections 3.2.1 and 3.2.2). 
The cells treated with PRW at the concentration of 400 ^ig/mL had remarkable cell 
morphological changes, including enlargement, macrophage-like cell patterns with 
pseudopodia, and adherence on the cell plates, but those treated with mPRSon had 
only a slight change in cell morphology (section 3.2.3). Moreover, PRW at the 
concentration of 100 ^ig/mL (lOOW) and 400 ^ig/mL (400W) stimulated phenotypic 
maturation in THP-1 cells by increasing the expression of surface markers CD14, 
CDllb, and also the MHC class II molecule HLA-DR which provided a linkage 
between the innate and adaptive immunity by present antigen to CD4+ T cells, after 
treatment for 48 hours (section 3.2.4). PRW also up-regulated phagocytic ability of 
monocytic THP-1 cells by increasing the uptake ofFITC-DX (section 3.2.5). 
mPRSon at 100 ^ig/mL (lOOS) and 400 |ig/mL (400S) significantly increased the 
ability of nitrite production in THP-1 cells (section 3.2.6). Both mPRSon and PRW 
were found to activate this monocytic cell line to release cytokines that recruited and 
activated neutrophils and monocytes (section 3.2.8). PRW could also stimulate the 
release of cytokines that activated NK cells, T and B lymphocytes. PRW at the 
concentration of400 ^ig/mL significantly up-regulated the sub-Gl phase of cell cycle 
after treatment for 48 hours (section 3.2.9). This might indicate that it could trigger 
the onset of apoptosis in THP-1 cells. 
It was concluded that PRW might have the potential to stimulate terminal 
differentiation in monocytic THP-1 cells, which might provide an alternative 
approach to treat leukemia by limiting its replicate ability and causing cell death in 
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leukemic cells. On the other hand, mPRSon could stimulate the production of 
cytotoxic reactive nitrogen species in monocytic THP-1 cells. This might help the 
patients with immunodeficiency diseases in the generation of RNS to fight against 
fungal and bacterial infection. 
Since these two sclerotial polysaccharides had large molecular weight, they 
should activate the THP-1 cells by binding to the pattem recognition receptors (PRRs) 
on the cell surface; instead of penetrating into the cells to activate the immune 
responses. Pre-treatment of mPRSon (a homoglucan) with THP-1 cells blocked the 
binding of dectin-1 mAb (section 3.2.10). This matched with previous findings that 
the dectin-1 receptor mainly recognized P-glucan-like polysaccharides such as 
zymosan (Brown and Gordon, 2001). It suggested that mPRSon activated the 
immune responses through the binding of dectin-1 receptors. On the other hand, 
pre-treatment ofPRW (a protein and mannose-containing polysaccharide) with 
THP-1 cells blocked the binding of CR3 mAb (section 3.2.10). This agreed with 
the properties of the CR3 receptors that recognize polysaccharides containing 
mannose and glucose (Thornton et al., 1996). The activation of CR3 receptors 
could only promote phagocytosis but not the release ofROS in THP-1 cells (Wright 
and Sliverstein, 1983). This matched with the present result that PRW greatly 
inhibited the production of ROS in THP-1 cells (section 3.2.7). Taken all these data 
into consideration, PRW should bind with CR3 receptors to trigger the immune 
responses such as morphological changes and adhesion, increase in phagocytic 
ability, and production of nitrite. It also suggested that CR3 recognized 
polysaccharide-protein complex containing mannose and glucose. 
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This project originally aimed to investigate the immune responses in human 
dendritic cells (DCs) by deriving it from monocytic THP-1 cells, since human 
monocytes could develop into immature DCs by addition of GM-CSF and IL-4 
(Berges et al，2005; Chan et al., 2005 and 2007). However, two unexprected 
results were found. The first one was that the THP-1 cells failed to activate some 
hematopoietic differentiation programs in response to stimulation with GM-CSF and 
IL-4 alone, which was most likely due to the origin ofTHP-1 cells from 
neoplastically transformed cell line. The differentiation of immature DC from 
THP-1 required a calcium ionophore, ionomycin that mediated intracellular calcium 
^ 1 
flux by up-regulating the cell membrane permeability to Ca ions (Berges et al., 
2005). The cytokines and ionomycin should be added before the treatment of the 
two sclerotial polysaccharides, to ensure the monocytic THP-1 cells have been 
differentiated into immature DCs first. However, the cells have already became 
enlarged with macrophage-like cell pattem before adding GMCSF, IL-4 and 
ionomycin (data not shown), so it was difficult to distinguish the morphological 
change came from the treatment of the two mushroom sclerotial polysaccharides 
after the addition of cytokines and ionomycin. The second one was that 
homoglycan such as zymosan was shown to have no effect in the expression of DC 
maturation markers, endocytosis, and production of cytokines on THP-l-derived 
DCs (Chan et al.，2008). Taken into consideration of the above facts in addition 
that the supply ofhuman bone marrow was limited, we switched to differentiate 
immature DCs using murine bone marrow cells for our subsequent investigation for 
immune responses as described in section 2.1.4. 
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3.3 Immune responses for murine immature BMDCs 
3.3.1 Inhibition effects on murine immature BMDCs 
Apart from monocytes / macrophages, dendritic cells are believed to be the most 
effective antigen-presenting cells. Similar to the immunomodulatory study in 
monocytic THP-1 cells, MTT cell viability assay was used to examine whether there 
was any response of murine immature BMDCs to the two PR mushroom 
polysaccharides before the other immunomodulatory activities were tested. 
Furthermore, since the immune responses triggered by 400 ^ig/mL ofboth mPRSon 
and PRW were most potent in monocytic THP-1 cells (3.2), this concentration was 
selected for the immunomodulatory study of murine immature BMDCs. 
After treatment for 48 hours, both mPRSon and PRW inhibited the proliferation 
of murine immature BMDCs significantly (Table 3.6). The inhibitory effect of 
PRW (45.36%), was very much higher than the response triggered by mPRSon 
(3.43%), indicating that a stronger differentiation commitment to mature BMDCs in 
the former, as decreases in proliferation and viability were one of the characteristics 
of cell differentiation (Berges et cd., 2005). 
Table 3.6: The inhibitory effect triggered by Polyporus rhinocerus extracts on 
murine immature BMDCs after 48 hours incubation compared with medium alone as 
negative control using MTT cell viability assay. 
400^g/mL of mPRSon (400S) 400^igAnL of PRW (400W) 
Inhibition effect ( % j 3.43 士 0.45 # 45.36 士 1.36 *** 
Data are means of three independent experiments (±SD). Student's Mest was used 
to compare treatment groups with negative control, and significant differences were 
denoted by *** p < 0.0005, # p < 0.01. 
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3.3.2 Change in cell morphology of murine immature BMDCs 
Cell morphology and cell adhesion were examined under a phase contrast 
microscope after treatment for 48 hours (Figure 3.14). Murine immature BMDCs 
still remained in suspension and were nearly spherical in shape under normal culture 
condition. Both of 400S- and 400W-treated murine immature BMDCs showed 
observable change in cell morphology. The 400S-treated cells only showed slightly 
morphological change with some dendrites but no adhesion on culture plate was 
found, while the 400W-treated cells had enlarged veils and dendrites which became 
adherent on the surface of culture plates (Figure 3.14). 
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Figure 3.12: The effect of morphological change triggered by Polyporus rhinocerus 
extracts for (A) medium alone as a negative control (CTRL), (B) 400^ig/mL of 
mPRSon (400S), and (C) 400^ig/mL ofPRW (400W) on immature BMDCs after 48 
hours incubation shown under phase-contrast microscope (400X). 
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3.3.3 Phenotypic maturation of murine immature BMDCs 
In order to activate T cells, DCs required high cell surface expression of 
co-stimulatory molecules CD40, CD80, and CD86 and major histocompatibility 
complex class II (MHC II) molecule, which are regarded as the phenotypic 
maturation of immature DCs. Either one of the co-stimulating molecules indicated 
that immature BMDCs have been differentiated into mature ones. (Geissmarm et al., 
2008; Kapsenberg, 2003; Kindt et al.，2007; Naik, 2008). The surface expression of 
co-stimulating molecules, CD40, CD80, CD86, and MHC class II molecule, 
I-Ad/I-Ed, were detected by flow cytometry and showed as mean fluorescence 
intensity (Figure 3.15). 
By comparing with CTRL, all co-stimulatory molecules and MHC class II 
molecule were up-regulated after murine immature BMDCs were treated with 400S 
and 400W with 400W having a stronger stimulation on the cells (Figure 3.15). 
400W could significantly increase the surface expression of CD40 from 3.59 to 
49.99 {p < 0.05), CD80 from 59.61 to 225.67 (p < 0.05), and CD86 from 64.44 to 
337.06 {p < 0.05) compared with the negative control (Figure 3.15 A-C). On the 
other hand, 400S could only stimulate the surface expression of CD86 significantly 
from 64.44% to 95.32 {p < 0.05), although other co-stimulatory molecules and MHC 
class II molecule were also up-regulated. 
These results might indicate that 400S could stimulate the immature DCs 
differentiated to mature DCs with significantly up-regulation of co-stimulatory 
molecule CD86 which in tum to trigger CD28 on T cells. 400W could stimulate the 
immature DCs differentiated to mature DCs, demonstrated by the significant 
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up-regulation of co-stimulatory molecule CD80 and CD86. These triggered CD28 
on T cells and also increased the expression of CD40 which interacted with CD40L 
on T cells to provide the optimal expression of the profile of T-cell-polarizing factors. 
Further investigation on the functional maturation was required to confirm the 
maturation of DCs. 
3.3.4 Down-regulation of endocytosis in murine immature BMDCs 
Besides using phenotype switch, the functional assessment for treated DCs is 
important to evaluate DC maturation. One of the functions is the endocytic activity. 
It is known that immature DCs engulf and recognize antigens with the help of PPRs, 
but upon maturation, DCs subsequently lose this endocytic ability to become 
antigen-presenting (Geissmann et al., 2008 and 2010; Kapsenberg, 2003; Naik, 
2008). The endocytic activity was examined by the same method used in the 
determination of phagocytic ability in monocytic THP-1 cells in section 3.2.5. 
Comparing with the value ofCTRL (11.40), the uptake ofFITC-DX by BMDCs 
was significantly (p < 0.005) down-regulated in 400S treatment (5.99), and 400W 
treatment (3.45), indicating that 400S and 400W treated DCs had lost the function of 
endocytosis which indicated their functional maturity (Figure 3.16). It was revealed 
that G. lucidum mycelium polysaccharides treated DCs also had reduction of 
endocytic activity shown by the uptake of FITC-DX, suggesting that the cells were 
functionally mature, while G. lucidum spore polysaccharides treated DCs retained 
their antigen-engulfing potential, implying that the cells remained immature (Chan et 
a l 2005 and 2007). 
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Figure 3.13: Flow cytometry analysis of surface markers (A) CD40, (B) CD80, (C) 
CD86, and (D) I-Ad/I-Ed expression on immature BMDCs upon treatment with 
Polyporus rhinocerus extracts, 400^g/mL of mPRSon (400S), and 400p,g/mL of 
PRW (400W), or medium alone as a negative control (CTRL). The results were 
collected as the percentage of positive cells subtracted by that of isotype control 
antibody-stained cells. Data are means of three independent experiments (±SD). 
Student's Mest was used to compare treatment groups with CTRL group, and 
significant difference was denoted by * p < 0.05. 
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Figure 3.13: Phagocytic ability of immature BMDCs treated with Polyporus 
rhinocerus extracts, 400^ig/mL ofmPRSon (400S), and 400|igAnL ofPRW (400W), 
or medium alone as a negative control (CTRL) after 48 hours. Treated immature 
BMDCs were incubated with fluorescein isothiocyanate-labeled dextrans (FITC-DX) 
for 1 hour at 37°C (white bar), and then washed three times. Parallel experiments 
were performed for all samples at 4°C (black bar) to rule out unspecific binding of 
FITC-DX. The cells incubated with phosphate-buffered saline (PBS) were worked 
as negative control to serve as background fluorescence. After normalized with the 
background fluorescence，the final values (Grey bars) are determined by the values 
obtained at 4°C subtracted from the values obtained at 37°C which in tum to obtain 
grey bars. Data are means of three independent experiments (±SD). Student's 
/^ -test was used to compare treatment groups with CTRL group, and significant 
differences were denoted by ** p < 0.005. 
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3.3.5 Increased nitrite production 
In order to know whether PR mushroom polysaccharides-treated DCs have been 
differentiated to immunostimulatory DCs (TipDCs), the level o fNO was measured 
by means of nitrite using the same method as monocytic THP-1 cells, the Griess 
Reagent System in section 3.2.6. Although there was no significant difference 
between CTRL and 400S-treated cells in the level of nitrite, 400W significantly 
increased {p < 0.001) the production of nitrite on immature BMDCs (Figure 3.17). 
After incubation for 48 hours, 400W-treated immature BMDCs produced 57.15 ^M 
which was very much higher than the production of CTRL which was 2.17 \iM. 
This might happen when immature DCs were differentiated into TipDCs, since the 
production ofNO is one of the characteristics of TipDCs. TipDCs released NO to 
trigger the relaxation of adjacent blood vessels, so as to further promote the influx of 
other immune cells to the target site (Geissmann et al, 2008 and 2010). 
3.3.6 Decreased expression of CDllc in PRW-treated immature BMDCs 
Another characteristic of TipDCs is the intermediate expression of surface 
marker CD 11 c. To confirm whether 400W-treated immature BMDCs were 
differentiated into TipDCs, the surface expression of CD1 lc was examined by flow 
cytometry after incubation for 48 hours. By comparing with the untreated cells, 
400S-treated immature BMDCs expressed a similar level of CDllc , while those 
treated with 400W showed a significant reduction of CD1 lc expression {p < 0.05) 
(Figure 3• 18). Based on these data, it seemed that 400W-treated immature BMDCs 
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Figure 3.14: Nitrite production upon treatment of Polyporus rhinocerus extracts, 
400^ig/mL ofmPRSon (400S), and 400^ig/mL ofPRW (400W), or medium alone as a 
negative control (CTRL), for 24 and 48 hours. Data are means of three independent 
experiments (±SD). Student's Mest was used to compare treatment groups with 
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Figure 3.15: Flow cytometry analysis of surface markers CDllc expression on 
immature BMDCs upon treatment with Polyporus rhinocerus extracts, 400p<gAnL of 
mPRSon (400S), and 400^ig/mL ofPRW (400W), or medium alone as a negative 
control (CTRL). The results were collected as the percentage of positive cells 
subtracted by that of isotype control antibody-stained cells. Data are means of three 
independent experiments (±SD). Student's "test was used to compare treatment 
groups with CTRL group, and significant difference was denoted by *p < 0.05. 
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3.3.7 Cytokine profile detection 
Upon stimulation, DCs release a range of cytokines such as T cell polarizing 
factors to activate T cells, so as to mediate the inflammatory reactions and regulate 
the immunity (Geissmann et al., 208 and 2010; Kapsenberg, 2003; Naik, 2008). 
The culture medium containing the cytokines released by treated- and non-treated 
immature BMDCs after 24 and 48 hours were examined by a mouse cytokine array 
(Figure3.19). 
Treated immature BMDCs secreted larger amounts of some cytokines than 
untreated cells as shown in the map of the mouse cytokine array (appendix). By 
compared with the negative control, 400S-treated immature BMDCs had a higher 
expression of some major cytokines including macrophage inflammatory protein 1 
alpha (MIP-la), macrophage inflammatory protein 2 (MIP-2), and Thrombopoietin 
(TPO) as well as some minor ones including interleukin 2 (IL-2), keratinocyte 
chemoattractant (KC), and Leptin, after treatment for 48 hours (Figure 3.19 B and E). 
However, the patterns of cytokines released by 400W- treated immature 
BMDCs were more complicated and had stronger signals than 400S-treated cells 
(Figure 3.19). 400W-treated cells had a higher expression of IL-6, monocyte 
chemoattractant protein 5 (MCP-5), MIP-la, MIP-2, RANTES, two forms 
(IL-12p40p70 and IL-12p70) ofinterleukine 12 (IL-12), tissue inhibitions of 
metalloproteinase 1 (JIMP-1), interferon gamma (IFN-y), KC, MCP-1, and 
granulocyte colony stimulating factor (GCSF) than those of 400S-treated cells after 
24 hours (Figure 3.19 B and C). The signals of these cytokines were stronger after 
48 hours, indicating that these cytokines were accumulated within 48 hours (Figure 
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3.19 C and F). The 400W-treated cells also released Thrombopoietin (TPO) and 
IL-2 after 48 hours (Figure 3.19 F). 
MIP-la, MIP-2, RANTES, and Eotaxin belong to the CCR5 subgroup ofthe 
CC chemokine family (Kindt et al, 2007). MIP-2 and RANTES are 
chemoattactants and activators o f T cells, neutrophils and NK cells, especially 
monocytes and macropahges. Eotaxin has been shown to be a potent 
chemoattractant for eosinophils during inflammation (Rothenberg et al., 1995). 
MIP-la is a chemoattractant and activators of macrophages and NK cells. 
(Salazar-Mather et al., 2000). IFN-y is type 1 cytokine that activates macrophages, 
increases the expression of MHC class II molecules, and also the antigen 
presentation (Kindt et al.，2007). MCP-5 is strongly chemotactic for monocytes and 
peritoneal macrophages. MCP-1 is also known as monocyte chemotactic and 
activating factor (MCAF) which is a chemoattractant to attract monocytes, T 
lymphocytes, and NK cells (Baggiolini et al., 1997; Carr et al., 1994; Rollins 1997). 
GCSF is a hematopoietic cytokine that stimulates the production and function of 
neutrophils (Kindt et al.，2007). KC has been considered to be a murine homologue 
ofhuman GRO (Oquendo et al., 1989) and was identified as chemoattractant for 
monocytes and neutrophils (Nasu et al, 2001). TIMP-1 is the inhibitors of matrix 
metalloproteinases (MMPs) which are involved in the breakdown of connective 
tissues and tumor-induced angiogenesis (Johnson et al，2002). Thrombopoietin 
(TPO) is also a hematopoietic cytokine that stimulates the megakaryocyte to produce 
platelets (Kindt et al，2007)- Leptin is a protein hormone that plays a key role in 
regulating energy intake and increasing energy expenditure and metabolism 
measured as increased oxygen consumption, higher body temperature and loss of 
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adipose tissue mass, which might support the function of iNOS (Pelleymounter et al., 
1995; Becerril etal.,20l0) 
IL-2 is a type I cytokine that plays a central role in the proliferation of B and 
most T lymphocytes, and also the expansion and activation o f N K cells (Croft and 
Swain, 1991 ； Kindt et al., 2007). IL-6 is both pro-inflammatory and 
anti-inflammatory, involves in regulation of acute phase reactions, influencing 
adaptive immunity through proliferation and antibody secretion of B cells, and also 
haematopoiesis (Heinrich et al，2003). IL-12 is a disulfide-linked heterodimeric 
cytokine composed of a 35 kDa light chain Q)35) and a 40 kDa heavy chain (p40) 
resulting in the only biologically active 70 kDa (p70) form of IL-12. Both the 
pre-form and the bioactive form of IL-12 were increased in expression (Figure 3.19). 
IL-12 is a type I cytokine to modulate adaptive immune response and also stimulates 
NK cells (Kindt et al，2007). It could induce T cells to produce IFN-y (Trinchier, 
1998). IL-10 was not found in the culture medium in 400W-treated immature 
BMDCs, and the production of IL-12 could be facilitated by the absence ofIL-10 
(Hseih et al 1993). 
To sum up, mPRSon and PRW could activate immature BMDCs to secrete a 
wide range of cytokines which in tum stimulate the chemotaxis of other immune 
cells to promote their functions. In particular, mPRSon was mainly responsible for 
recruitment and activation of monocytes, macrophages, and neutrophils, while PRW 
secreted Tnl cytokines to promote the polarization o f T cells in addition to the influx 
and activation of monocytes, macrophages, and neutrophils, and NK cells. 
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Figure 3.16: Cytokines release upon treatment of Polyporus rhinocerus extracts on 
immature BMDCs, 400|ag/mL (400S) ofmPRSon, and 400^igAnL (400W) ofPRW, 
or medium alone as a negative control (CTRL), for 24 and 48 hours, measured by 
cytokines profile array. Coloured squares indicate different human cytokines. The 
positive results were shown as dark dots, and the higher intensity represented as the 
higher concentration of cytokines released from the cells. Each type of cytokines 
was determined in duplicate representing as a pair of vertical dots in the array. 
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3.3.8 Surface receptors expression 
The main function of immature BMDCs is to recognize different exogenous and 
endogenous antigens mediated by PRRs (Geissmann et al, 2010; Kapsenberg, 2003). 
The interactions between mPRSon and PRW sclerotial polysaccharides with the 
receptors including dectin-1, CR3, and TLR2 in immature BMDCs were examined 
by flow cytometry using the same principle as in monocytic THP-1 cells in section 
3.2.10. 
For dectin-1, the binding of dectin-1 mAb was shown to be significantly 
(p<0.05) blocked in the cells pre-treated with 400W and 400S (Figure 3.20 A). 
The binding ofCR3 mAb was not blocked by both 400W and 400S (Figure 3.20B). 
The pretreatment of mPRSon and PRW could increase the surface expression of CR3 
(Figure 3.20 B). The binding ofTLR2 mAb was not affected by 400S. But its 
binding could be fully blocked by 400W showing a negative value of mean 
fluorescence intensity after normalized by its isotype, indicating that the TLR2 
receptors on the cells were fully occupied by 400W and no site was available for the 
TLR mAb (Figure 3.20 B). 
As mentioned in section 3.2.10, the chemical structure of mPRSon and PRW 
could affect the binding of receptors. Since mPRSon contained almost pure glucan 
with only little amount of proteins, and dectin-1 recognizes p-glucan containing 
polysaccharides or zymosans (Brown, 2006)，it was reasonable to find the significant 
blocking of dectin-1 mAb binding after the pretreatment of mPRSon, implying that 
mPRSon was mainly recognized by dectin-1. 
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Surprisingly, unlike the results in monocytic THP-1, 400W could 
significantly O^^ <0.05) block the binding of dectin-1 and TLR2 mAbs in immature 
BMDCs, implying that PRW might be recognized by both dectin-1 and TLR2. This 
suggested that the same mushroom polysaccharide could be recognized by different 
receptors in monocytes/macrophages and BMDCs. Actually, it was revealed that 
both dectin-1 and TLR2 could recognize zymosans which collaborated to induce the 
inflammatory responses in DCs through activation of nuclear factor kappa B 
(Gantner et al.，2003). Dectin-1 and TLR2 were synergistic in stimulating the 
production of cytokines such as IL-12 (Gantner et al, 2003). This might be the 
reason why the production ofIL-12 was so remarkable in 400W-treated immature 
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Figure 3.17: (A) Dectin-1 / P-glucan receptor; (B) CDllb / Mac-1; (C) TLR2 
expressions upon treatment of Polyporus rhinocerus extracts on immature BMDCs, 
400^ig/mL (400S) ofmPRSon, and 400^ig/mL (400W) ofPRW, or medium alone as a 
negative control (CTRL) for 6 hours. Data are means of three independent 
experiments (±SD). Tukey's multiple comparison test was used, and different 
letters indicate significant different at a confidence level of 5% (p<0.05). 
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3.3.9 Summary 
Dendritic cells (DCs) are the most effective antigen-presenting cells. In this 
study, murine immature bone-marrow-derived dendritic cells (BMDCs) was selected 
for ex vivo immunomodulatory studies of DCs. PRW at the concentration of 400 
|xg/mL (400W) showed a stronger inhibitory effect than the response triggered by 
mPRSon at the same concentration (400S) on immature BMDCs (section 3.3.1). 
This might imply that PRW triggered a stronger cell differentiation commitment to 
mature BMDCs, since decrease in proliferation and viability were the characteristics 
of cell differentiation (Berges et al., 2005). It was found that 400W triggered a 
stronger morphological change than 400S (section 3.3.2). 400W-treated immature 
BMDCs changed from a suspension of nearly spherical in shape to enlarged cells 
with veils and dendrites that adhered on the surface of culture plates. 400S 
stimulated immature BMDCs to have some dendrites but no adhesion property was 
found. 
Moreover, 400W activated the phenotypic maturation in immature BMDCs by 
significantly up-regulating co-stimulating molecules CD40, CD 80, and CD86, while 
400S significantly increased the expression of CD86 only (section 3.3.3). The 
up-regulated expression of co-stimulating molecules CD80 and CD86 should trigger 
CD28 on T cells, and the increase in the expression of CD40 should interact with 
CD40L on T cells in order to have the optimal expression of the profile of 
T-cell-polarizing factors (section 3.3.3) (Geissmann et al., 2008 and 2010; 
Kapsenberg, 2003; Naik, 2008). This implied that the 400S- and 400W-treated 
immature BMDCs could become phenotypic matured. 
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Reduction of endocytic ability is one of the charaterisitcs when immature 
BMDCs differentiated into mature ones. 400S and 400W significantly 
down-regulated the endocytic capability in immature BMDCs, shown by a decrease 
in the uptake of FITC-DX compared with the negative control (section 3.3.4). Both 
mPRSon and PRW stimulated the secretion of a wide range of cytokines that recruit 
and activate different types of innature immune cells, and PRW also stimulated 
cytokines that promote the polarization of T cells (section 3.3.7). These indicated 
that the 400S- and 400W-treated immature BMDCs were not only phenotypic mature, 
but also became functional matured. 
PRW-treated immature BMDCs had ability to secrete nitrite (section 3.3.5), and 
also significantly down-regulated the expression of surface marker CDllc (section 
3.3.6). These suggested that 400W could stimulate immature BMDCs to 
differentiate into immunostimulatory DCs (TipDCs) instead of the classical mature 
DCs (Geissmann et al, 2008 and 2010). 
The pre-treatment of mPRSon on immature BMDCs blocked the binding of 
dectin-1 mAb (section 3.2.10). This implied that the homoglucan mPRSon 
activated the immune responses through the binding of dectin-1 receptor which was 
responsible for recognizing P-glucan-like polysaccharides such as zymosan (Brown 
and Gordon, 2001). On the other hand, the pre-treatment ofPRW on immature 
BMDCs blocked the binding of dectin-1 and TLR2 mAbs (section 3.2.10). These 
results were different from these obtained from the pre-treatment ofPRW on 
monocytic THP-1 cells in which PRW was found to be recognized by the CR3 
receptors. This suggested that the same type of mushroom polysaccharide such as 
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PRW could be recognized by different receptors in different immune cells, 
monocytes/macrophages and BMDCs. Both dectin-1 and TLR2 might collaborate to 
induce the inflammatory responses in BMDCs through activation of nuclear factor 
kappa B (Gantner et al, 2003), and they might be synergistic in stimulating the 
remarkable production ofIL-12 (Gantner et al., 2003). 
More importantly, previous studies have shown that after 48-hour treatment, 
both of crude G. lucidum mycelium polysaccharides (GL-M) and pure GL mycelium 
polysaccharides (GL-PS) isolated by hot water extraction could also significantly 
up-regulate the surface co-stimulatory molecules (CD40, CD80, and CD86) and 
MHC class II molecule (HLA-DR), as well as reduced the endocytic ability on 
human monocyte-derived immature DCs, indicating the cells might be differentiated 
to mature DCs (Chan et al., 2005 and 2007). However, crude G. lucidum spores 
polysaccharides (GL-S) isolated by absolute ethanol could not induce any significant 
change in the surface expression of neither co-stimulatory molecules nor MHC class 
II molecules (Chan et aL’ 2005 and 2007). Treatment of GL-S also retained the 
antigen-engulfing potential on human monocyte-derived immature DCs that a 
regulatory immature DCs which had anti-proliferative effect of T cells in DC:T 
co-culture of mixed lymphocyte reaction (MLR). Different polysaccharides 
isolated from different parts of G. lucidum could therefore trigger different responses 
in human monocyte-derived DCs. The polysaccharides in the form of p_l,3; 
1,6-glucan is the major active component of GL-M/GL-PS, while triterpenes is the 
one in GL-S. In the same study, barley extract (MSK-BG) which was used for 
comparison, was a pure linear P_l,3; 1,4-glucan and had no immunomodulatory 
activity compared with the negative control (Chan et al, 2007). This suggested that 
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glycosidic linkages in the p-glucans might be important for the initiation of 
immunomodulatory activity in DCs. PRW had a relatively high protein content 
than mPRSon (53.54%), which had a similar immunomodulatory effects on 
phenotypic maturation to that triggered by GL-M and GL-PS. The protein content 
in GL-M (20.1%) was also relatively higher than that in GL-S (5.2%) (Chan et al, 
2007). GL-PS is a polysaccharide-peptide complex with molecular weight of 58.49 
X 10^ Da and consisted of mannose as the major monosaccharide content. These 
were similar to the properties of PRW which had a high molecular weight ( > 78.8 x 
10^ Da) and consisted of mannose as the second major sugar content. Therefore, it 
seemed that PRW and the polysaccharides isolated from mycelium of G. lucidum had 
similar chemical composition as well as immunomodulatory properties. 
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Chapter 4 Conclusion and future works 
Previous studies have reported that the hot-water fraction and the cold-alkali 
sonication fraction isolated from the mushroom sclerotium, Polyporus rhinocerus, 
had remarkable immunomodulatory and antitumor properties (Lai, 2005 and 2008). 
In the present study, hot water extraction and cold-alkali sonication extraction 
methods in addition to micronization technique were chosen to isolate extracts for 
further investigation for their immunomodulatory properties on two major 
antigen-presenting cells, monocytes and dendritic cells. Micronization slightly 
improved the yield of extraction and observably increased the solubility of the 
sonication-associated cold alkali-soluble extract (mPRSon) to give a clear solution. 
The hot water extract (PRW) was found to be a protein-containing polysaccharide, 
while the mPRSon extract to be a homoglycan, which activated different immune 
responses in monocytic THP-1 cell line. PRW seemed to have a potential to 
activate the terminal cell differentiation by MTT and BrdU cell proliferation assays 
and PI staining for cell cycle, while mPRSon activated a significant amount of 
reactive nitrogen species shown by Griess Reagent System. It implied that PRW 
may also trigger cell differentiation in other leukemic cells, which considered 
necessary for further investigation. It was proven that both PRW and mPRSon 
could up-regulate the phagocytic ability by the uptake ofFITC-DX assay and also 
stimulate the secretion of cytokines in THP-1 cell to recruit and activate other 
immune cells by human cytokines profile array. 
Furthermore, PRW was found to more potent than mPRSon in activating 
immature BMDCs. The treated-cells seemed to differentiate into immunostimulatory 
DCs with the release ofIL-12 and nitrite in the culture medium determined by mouse 
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cytokines profile array and Griess Reagent System, respectively. Therefore, the 
DC:T co-culture of mixed lymphocyte reaction should be investigated to show the 
activation of naiVe T cells by PRW-treated BMDCs in the future. 
Because of the key role of pattem recognition receptors for glucan to carry out 
the biological functions of the high molecular weight mushroom sclerotial 
polysaccharides, it was important to find out which receptors are involved in 
mediating the recognition and triggering the immune responses. The mPRSon 
extract was found to activate the immune responses through the dectin-1 receptor in 
both monocytic THP-1 cells and BMDCs, while PRW extract was shown to bind to 
the CR3 receptors only in monocytic THP-1 cells but bind to both the dectin-1 and 
TLR2 receptors in BMDCs. The activation of receptors was shown to affect the 
immune response that the the binding of CR3 receptors by PRW extract inhibited the 
reactive oxygen species in THP-1 cells (Wright and Sliverstein，1983). To further 
confirm the results of these extracts, the immune functions ofboth monocytic THP-1 
cells and BMDCs should be investigated after the pre-treatment of the particular 
monoclonal antibodies to block the binding of the extracts in the future, to 
investigate their activation effects on the cells. Moreover, not only the chemical 
composition, but also the detailed physical structure of the two extracts should be 
examined to show the detailed differences in the glycosidic linkages between the 
monosaccharide residues, so that the active components in the extracts can be 
fractioned, and the interactions between these polysaccharide/protein-containing 
polysaccharide and their corresponding receptors can be explained in detailed. 
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Appendix 
RayBio® Human Cytokine Antibody Array 3 
Pos Pos Neg Neg ENA-78 GCSF GM-CSF GRO GRO-alpha 1-309 IL-1 alpha IL-1 beta 
Pos Pos Neg Neg ENA-78 GCSF GM-CSF GRO GRO-alpha 1-309 IL-1 alpha IL-1 beta 
IL-2 IL-3 I L 4 IL-5 IL-6 IL-7 IL-8 IL-10 IL-12 p40p70 IL-13 IL-15 ffN-gamma 
IL-2 IL-3 IL"4 IL-5 IL-6 IL-7 IL-8 IL-10 IL-12 p40p70 IL-13 IL-15 ffN-gamma 
MCP-1 MCP-2 MCP-3 MCSF MDC MIG MIP-1 delta RANTES SCF SDF-1 TARC TGF- beta 1 
MCP-1 MCP-2 MCP-3 MCSF MDC MIG MIP-1 delta RANTES SCF SDF-1 TARC TGF- beta 1 
TNF-alpha TNF-beta EGF IGF-I Angiogenin Oncostatin M Thrombopoietin VEGF PDGF BB Leptin Neg Pos 
TNF-alpha TNF-beta EGF IGF-I Angiogenin Oncostatin M Thrombopoietin VEGF PDGF BB Leptin Neg Pos 
RayBio® Mouse Cytokine Antibody Array 2 
Pos Pos Neg Neg 6Ckine CTACK Eotaxin GCSF GM-CSF IL-2 IL-3 IL^4 
Pos Pos Neg Neg 6Ckine CTACK Eotaxin GCSF GM-CSF IL-2 IL-3 IL^ 
IL-5 IL-6 IL-9 IL-10 IL-12 p40p70 IL-12p70 IL-13 IL-17 IFN-gamma KC Leptin MCP-1 
IL-5 IL-6 IL-9 IL-10 IL-12 p40p70 IL-12p70 IL-13 IL-17 IFN-gamma KC Leptin MCP-1 
MCP-5 MIP-1 alpha MIP-2 MIP-3 beta RANTES SCF sTNFRI TARC TIMP-1 TNF-alpha Thrombopoietin VEGF 
MCP-5 MIP-1 alpha MIP-2 MIP-3 beta RANTES SCF sTNFRI TARC TIMP-1 TNF-alpha Thrombopoietin VEGF 
BLANK BLANK BLANK BLANK BLANK BLANK BLANK BLANK BLANK BLANK BLANK Pos 
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